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Abstract 
Humans are under a constant influence from a vast number of environmental mutagens. 
Many of these are genotoxic, and therefore a constant threat to the integrity of the human 
genome. A reduced fertility potential has been observed in couples from industrialised areas, 
and Norwegian and Danish men have shown to have a reduced sperm quality compared to 
men in other countries from the Northern Europe. A connection between this reduced 
fertility and a continuous exposure to environmental mutagens may be expected.  
The ubiquitous environmental mutagen Benzo(a)pyrene (BaP) has been studied in this 
master thesis, with the aim to examine potential genotoxic damage in male reproductive cells 
and the possible transmission of such damage to the embryo. Paternal exposure to BaP is 
embryo-toxic, and the sperm chromatin structure assay (SCSA) has been used to examine if 
there were enhanced levels of DNA damage in sperm cells from mice exposed to BaP in vivo 
(150 mg/kg i.p.). The use of knock out (Ogg1
-/-
) mice compared to wild type animals was 
proposed as a model for human toxicological testicular responses. Studies has shown that 
sperm cells hold a high amount of 7,8-diol-9,10-epoxide (BPDE)-DNA adducts after BaP-
exposure. However, the SCSA showed no statistical significant differences in the amount of 
DNA damage between BaP-exposed, vehicle and control animals. This indicates that BaP-
exposure does not induce sperm DNA strand breaks and that the SCSA is an unsuited assay 
for measuring BaP-induced DNA alterations. A study has shown that sperm BPDE-DNA 
adducts may persist during the first embryonic cell divisions. Work with verifying this 
observation required a procedure for staining of BPDE-DNA adducts and a method for 
handling embryos before staining of potential adducts. This latter procedure was challenging 
and gave poor results, although the procedure and method is improved for future work with 
immunostaining of embryos.  
Somatic mutagens are considered mutagenic also to male germ cells if the substance reaches 
testicular tissue. An in vivo somatic mutation assay called the Pig-a assay has also been a 
part of this master project. Establishment of this assay has included a positive control 
experiment with N-ethyl-N-nitrosourea (ENU) exposed mice. The assay proved to be 
sensitive for detecting somatic mutations in blood samples from mice, and suggestions for 
improvements has been made. Further work with the Pig-a assay seems promising, and the 
assay may have great potential in regulatory toxicology studies on chemical agents.  
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Abbrevations 
8-oxoG 7,8-dihydro-8-oxodeoxyguanosine 
AhR  Aryl Hydrocarbon receptor 
AKR  Aldo-Keto Reductase 
AO  Acridin Orange 
ANOVA  Analysis of Variance 
APC  Allophycocyanin 
ARNT  Aryl hydrocarbon receptor nuclear translocator 
ATP  Adenosine triphosphate  
BaP  Benzo(a)pyrene 
BER  Base excision repair 
BSS  Buffered salt solution 
Bw  Bodyweight  
BPDE  7,8-diol-9,10-epoxide 
BSA  Bovine Serum albumin 
Comet  Single Cell Gel Electrophoresis 
CYP  Cytochrome p-450 
ddH20  Double distilled water 
DFI  DNA fragmentation index 
DMSO Dimethyl sulphoxide  
DNA   Deoxyribonucleic acid 
DsDNA Double stranded DNA 
EDTA  Ethylenediaminetetraacetic acid 
EH  Epoxide hydrolase 
ENU  N-ethyl-N-nitrosourea 
FCS  Fetal bovine serum 
FITC  Fluorescein isothiocyanate 
FSH  Follicle stimulating hormone 
GPI  Glycosylphosphatidylinisotol 
GST  Glutathione-S-transferase  
HCG  Human Chorionic Gonadotropin  
HCl  Hydrogen Chloride  
ICC  Immunocytochemistry 
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i.p.  Intraperitoneal  
IVF  In vitro fertilization  
KO  Knock out 
KSOM Potassium simplex optimisation medium 
LDLo  Lethal Dose Low 
MEM  Minimum essential medium 
MIKT  Department of chemical toxicology  
MgCl  Magnesium chloride 
MRNA Messenger ribonucleic acid 
NADPH Nicotinamide adenine dinucleotide phosphate  
NER  Nucleotide excision repair 
NIPH  Norwegian Institute of Public Health  
OGG1  8-oxoguanine-DNA glycosylase  
PAH  Polycyclic aromatic hydrocarbon 
PBS  Phosphate buffered saline  
PE  Phycoerythrin 
Pig-a  phosphatidylinositol glycan anchor biosynthesis, class A 
PMSG  Pregnant Mare Serum Gonadotropin 
PMT   Photomultiplier tube 
RBC  Red blood cell 
RET  Reticulocyte 
RNA  Ribonucleic acid 
ROS  Reactive oxygen species 
SCSA  Sperm Chromatin Structure Assay 
SD  Standard deviation    
SE  Standard Error 
SsDNA Single stranded DNA 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labelling 
WT  Wild type  
XRE  Xenobiotic responsive element  
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1. Introduction 
1.1 General background  
Reproduction is an important element in life for most humans and for the evolutionary 
history of all species. In the last decades infertility has become a growing problem. 
Especially in the Western World an increasing amount of couples have difficulty with 
conceiving or complete the gestation and hence this has become a public health issue. The 
increasing infertility is caused by both female and male factors and to establish the 
background for this essential biological concern, insight and determined research is needed. 
In developed countries in the European Union, birth rates have decreased continuously 
during the past half century (Barratt et al., 2010). Scandinavian men have been found to have 
reduced scores in semen quality compared to men in other European countries. In a fertility 
study including men from the Northern Europe, Norwegian and Danish men had the lowest 
sperm concentrations, while Finnish and Estonian men had the highest sperm counts 
(Jørgensen et al., 2006) The risk for testicular cancer is also higher in Norway and Denmark 
compared to other European countries (Giwercman and Giwercman 2011; Jørgensen et al., 
2006). Testicular cancer typically arises from the germ cells in testis, and a correlation 
between infertility and testicular germ cell tumour has been observed (Hotaling and Walsh 
2009). The incidents of testicular cancer are generally increasing, especially among young 
men from 15 to 35 years. The occurrences are assumed to double every 15 to 25 years 
(Adami et al., 1994).  
There are numerous and complex causes for this observed direction of decreased fertility. A 
generally higher age of both men and woman when conceiving is observed and believed to 
be a contributing cause (Kidd et al., 2001). However, environmental and lifestyle factors are 
believed to have vast impact on both semen quality and testicular cancer. People in the 
Western world are daily exposed to a high number of toxicants from the approximately 
70.000 chemicals used in commerce (Anastas and Williamson 1996). Only a few of these 
chemicals have been evaluated in particular for their potential to cause sperm DNA damage 
and affect sperm cells (Barratt et al., 2010).  
Air pollution is a major contributor to human exposure of chemicals. Polycyclic aromatic 
hydrocarbons (PAHs), nitrated and halogenated organic compounds and metals are all 
present in the ambient air and can affect human health (Wolterbeek 2002). PAHs are some of 
Introduction 
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the most potent human carcinogens and many of them are also complete carcinogens with 
ability to both initiate and promote cancer (Boström et al., 2002). The use of cigarettes is 
still widely distributed although more than 60 carcinogens have been detected in mainstream 
and side stream cigarette smoke and tobacco has proved to be highly carcinogenic (Hecht 
2003; Lewtas 2007). PAHs are one of the important groups of carcinogenic compounds in 
cigarette smoke, and cigarette smoke is therefore a significant exposure source of PAHs to 
humans (Pfeifer et al., 2002). PAHs stimulate oxidative stress and have mutagenic and 
carcinogenic activity in human cells (Boström et al., 2002). These damaging effects may 
reduce human fertility, and are important to evaluate both in somatic cells and germ cells.  
Smoking may affect the fertility potential in both males and females, and smoking during 
gestation is a well known risk factor for damage and alterations of the offspring’s fitness and 
genetic integrity (Vine 1996; Zenzes et al., 1999a; Zenzes 2000). The maternal influence and 
input to the genetic composition of the embryo have for a long time been the main health 
focus before and during gestation. The fact that both sperm and egg contributes equally with 
50 % of the genes to the embryo, has given the paternal influence more attention (Delbes et 
al., 2010; Ji et al., 1997; Olsen et al., 2005; Zenzes 2000). Paternal smoking has proven to 
give a genetic transmission of modified DNA to the embryo, in the manner of detectable 
DNA adducts (Zenzes et al., 1999b).  
A broad assortment of studies has confirmed that toxicants in cigarettes affect the sperm 
cells in men by reduced sperm count, motility and an increase in sperm with abnormal 
morphology (Künzle et al., 2003; Vine 1996). One of these studies showed that heavily 
smoking men had a 19 % lower mean sperm concentration, and a 13 % lower mean 
percentage of motile sperm than non-smoking men (Ramlau-Hansen et al., 2006). In a study 
using in vitro fertilisation (IVF) it was shown that the number of clinical pregnancies was 
significantly reduced (40%) in smoking compared to non-smoking men (Zitzmann et al., 
2003). The DNA integrity of sperm cells can potentially be a valuable and independent 
indicator for infertility. 
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1.2 Male reproduction  
1.2.1 The male reproductive organ 
Sperm production (spermatogenesis) takes place in small seminiferous tubules of the testis 
which are all bounded by a basal membrane. Each tubule contains a fluid filled lumen that 
harvests the spermatozoa. The wall consists of developing germ cells and a permanent 
population of somatic Sertoli cells (Bellve et al., 1977; Borg et al., 2010). The Sertoli cells 
extend from the basal membrane out to the core of the lumen and are joined together in tight 
junctions that form the basis of the blood-testis barrier. The barrier controls the free 
exchange of endogenous substances as well as chemicals and drugs between the blood and 
fluid inside the seminiferous tubules. Degree of lipid solubility, size and ionisation are 
factors that determine whether a substance can penetrate the barrier or not. Small ionised 
hydrophobic substances most easily pass the barrier. Sertoli cells also provide nutrients, 
endocrine and paracrine substances and organise the delivery of mature spermatides into the 
tubular lumen (Borg et al., 2010; Holstein et al., 2003; Vander et al., 2001b). An interstitial 
space surrounds the seminiferous tubules and consists of connective tissue with Leydig cells, 
blood vessels and immune cells. Leydig cells are the most numerous cell type and a major 
producer of androgens and especially testosterone (Borg et al., 2010). 
The numerous seminiferous tubules gathers in a network called the rete testis. The small 
ducts are then called efferent ductules and leave the rete testis in one single duct. This 
gathers into the epididymis, which is loosely attached to the testis. The epididymis is divided 
into a head (caput), body (corpus) and tail (cauda). The epididymis from each testis leads to 
the vas deferens, which is a thick walled tube behind the urinary bladder bound together with 
blood vessels and nerves in the spermatic cord. Ducts from two seminal vesicles connect the 
vas deferenses and form two ejaculatory ducts that join the urethra out of the penis. 
Substance from the prostate gland is added during ejaculation to enhance the motility of the 
sperm (Vander et al., 2001b). Figure 1.1 shows the anatomy of the testis. 
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Figure 1.1 Anatomy of the human testis. The seminiferous tubules in testis are connected in the rete testis, 
which leads to the epididymis. Maturation of the spermatozoa occurs during transit through the caput, corpus 
and cauda epididymis (modified from Holstein et al., 2003). 
1.2.2 Spermatogenesis 
Spermatogenesis is the constant development of germ cells into mature sperm cells. The 
development includes series of events with establishment of a stem cell population, mitosis, 
meiosis and morphogenesis of the haploid germ cell (Borg et al., 2010). Already in the male 
embryo the testes contain germ cells that differentiate into spermatogonia. Spermatogonia 
multiply continuously in successive mitosis, and can be divided into a type A and type B. 
Type A belongs in the stem cell pool and type B starts the development towards future 
spermatides. The spermatogenesis first begins at puberty when type B spermatogonia 
differentiate into primary spermatocytes. These are developed to secondary spermatocytes in 
a first meiotic cell division and then into haploid spermatides in a second meiotic division. 
This is called the spermiogenesis and reduces the chromosome number from diploid (2n) to 
haploid (n) (figure 1.2). Spermiation is the transfer of spermatides by Sertoli cells out from 
the germinal epithelium and in to the lumen of the seminiferous tubule. Spermatozoa are 
then transferred into the rete testis and further into the epididymis (Campbell and Reece  
2005; Holstein et al., 2003).  
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Figure 1.2 Spermatogenesis in seminiferous tubules of the testis. Germ cells are present in the wall of the 
seminiferous tubules together with somatic Sertoli cells. Germ cells differentiated into spermatogonia 
proliferates by mitotic divisions, and some of them differentiate into primary diploid spermatocytes. The first 
meiotic cell division  produce two secondary spermatocytes, which undergo a second meiotic division into four 
haploid spermatides that are released into the lumen of the seminiferous tubules for transfer to the rete testis 
(modified from Campbell and Reece 2005).  
The spermatozoa in rete testis are structurally complete, although functionally still immature. 
The caput and corpus areas of the epididymis are adapted to give spermatozoa a further 
maturation and modification, which is essential for the sperm for fertilisation of the oocyte. 
The main function of the caudal part of the epididymis is sperm storage (Bedford 1994; Borg 
et al., 2010). Modifications during transfer in the epididymis include morphological changes, 
stabilisation of the chromatin and changes in membrane composition (Borg et al., 2010; 
Dadoune 2003). Spermatozoa gain an increase in potential for forward motility, which is 
essential for reaching the female reproductive tract. Capability to recognise, bind and fuse 
with the oocyte also arises in the epididymis, via increased ability to undergo acrosome 
reaction. All these modifications participate in a full maturation of the spermatozoa (Moore 
1998). The spermatogenesis in humans takes approximately 64 days (Heller and Clermont 
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1963). Additional 2-6 days is needed for the sperm to pass along the epididymis, and normal 
storage capacity in the cauda is 3-4 days (Moore 1998; Rowley et al., 1970). 
Spermatogenesis in mice takes approximately 35 days (Oakberg 1956), with an additional 7-
10 days for passage of sperm along the epididymis (Oakberg and Diminno 1960). There are 
several stages in the process of spermatogenesis and transfer through the epididymis that are 
sensitive for interfering agents and toxicants. 
1.2.3 The sperm cell 
The sperm cell is divided into a head and tail. The nucleus with condensed chromatin linked 
by protamines is localised in the head with a nuclear envelope and a perinuclear theca that 
forms a firm shell of proteins that covers the nucleus. The acrosome is localised in the apical 
part of the sperm cell, and contains enzymes needed for penetration of the oocyte. A 
mitochondrial sheath is present behind the head and provides adenosine triphosphate (ATP) 
for movement of the sperm cell. Behind the mitochondrial sheath is the tail or flagellum, 
which is composed of microtubules connected by dynein arms and generates motility (figure 
1.3) (De Jonge and Barratt 2006). The sperm cells in rodent and humans have different 
morphology, with a hook-shaped head in rodents and a spatula-shaped head in humans (De 
Jonge and Barratt 2006). Sperm cells could be an efficient way for studying exposure of 
environmental toxicants in humans, and variation in quality between populations or 
individuals could be linked to external environmental and lifestyle factors. Establishment of 
a complete relationship with sperm integrity and human fertility must be the ultimate goal 
(Sipinen et al., 2010).  
 
Figure 1.3 Schematic illustration of the anatomy of the sperm cell. The head is covered by an acrosome that 
facilitates binding to the oocyte. The head contains the nucleus with DNA. Behind the head is a mitochondrial 
sheath that provides ATP for movement of the flagellum (tail) (Borg et al., 2010).  
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1.2.4 DNA packing in sperm cells 
In the early stages of spermiogenesis, the chromatin in germ cells is arranged in the same 
way as somatic cells, with nucleosome core particles in histones that make transcription 
achievable. During development of the sperm cells in the spermiogenesis, the sperm 
chromatin modifies to a more resistant and compact structure. The histones get hyper-
acetylated and the nucleosomes are disassembled. Transcription stops when the enzyme 
Topoisomerase II unwinds the DNA helix, and transition proteins bind DNA. At the end of 
spermiogenesis, the transition proteins are replaced by small proteins called protamines, 
enabling a high degree of chromatin condensation  (Oliva 2006). During maturation of sperm 
cells in the epididymis, formation of disulphide bonds stabilises the nucleoprotamine 
complex. The DNA and protamines are coiled into compact toroides that contains about 50 
kb of DNA (D'Occhio et al., 2007). About ninety percent of mature sperm chromatin is 
bound to protamines, while the remaining 10 % is still linked by histones (Barratt et al., 
2010). During fertilisation and before the first cleavage division of the zygote, the 
nucleoprotamine structure is unpacked and restructured into nucleosomes. This is to obtain a 
looser chromatin configuration for DNA replication in the first mitotic division of the 
embryo (Oliva 2006). The protamine configuration in sperm cells give higher motility and 
protect the genetic material from external stress and physical disruption during transfer 
through the epididymis and female reproductive tract (Perreault 1992).  
1.3 Female reproduction 
1.3.1 The female reproductive organ 
The ovaries produce eggs and are located in the pelvis at each side of the uterus, and also 
secrete oestrogen and progesterone out in the blood stream. In humans the oviduct is divided 
into three parts named the Infundibulum, Ampulla and Isthmus. During ovulation the ovary 
releases a secondary oocyte into the Infundibulum. The oocyte is surrounded by a zona 
pelludica, corona radiate and nourishing cumulus cells. The oocyte complex travels into the 
Ampulla where fertilisation may occur. After fertilisation, the pre-implant embryo undergoes 
cleavages and is transported through the Isthmus to the uterus where it becomes implanted in 
the endometrium (figure 1.4) (Talbot and Riveles 2005).  
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Figure 1.4 Anatomy of the uterus, oviduct and ovary. The ovary produces eggs that are released one at the time 
as secondary oocytes into the Infundibulum, and transported further into the Ampulla for fertilisation. After 
fertilisation, the pre-implantation embryo travels down the Isthmus while it undergoes cell divisions. The pre-
implantation embryo reaches a compact morula stage and becomes a blastocyst before implantation in the 
uterus (Schuel 2006). 
1.3.2 Oogenesis  
Oogenesis is the production of an ovum that can be fertilised by a sperm cell. Differentiation 
of germ cells into ovary specific stem cells called oogonia already begins in the female 
embryo. Oogoniums proliferate by mitosis and starts meiosis, however, the progression 
arrests at prophase I. The cells are now called primary oocytes and will settle in ovary 
follicles until puberty. When puberty is reached, hormones including the follicle stimulating 
hormone (FSH) stimulate the primary oocytes. Meiosis I is completed and meiosis II starts, 
before another arrest at metaphase II. The primary oocytes have now developed into 
secondary oocytes with a first polar body. The oocytes are released one at the time as the 
follicles breaks open under ovulation each month. Meiosis carries on when a sperm fertilize 
the secondary oocyte in the Ampulla, and the oogenesis is accomplished when an ovum is 
produced, which is a haploid female reproductive gamete. All the meiotic events involve 
unequal cytokinesis and the smaller cells become polar bodies (Campbell and Reece 2005; 
Jaroudi and SenGupta 2007).  
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1.4 Fertilisation 
Fertilisation in mammals occur when the membranes of spermatozoa and oocyte fuses and 
the sperm cell enters the oocyte. The sperm cell must bind the zona pellucida and cumulus 
cells surrounding the oocyte. This event is irreversible and initiates a calcium dependent 
transduction pathway that results in exocytosis of the sperm acrosome. Hydrolytic enzymes 
are released and facilitate breakthrough of the sperm in the zona pellucida (Borg et al., 
2010). Following fertilisation, the oocyte completes meiosis and becomes a zygote where the 
oocyte and sperm chromosomes are captured in the female and male pro-nuclei. The 
chromosomes are replicated before the first cleavage of the zygote. The zygote starts the 
travel down the oviduct, and undergoes mitosis into smaller daughter cells called blastomers. 
Roughly around the 16-cell stage, the oocyte is called the morula and has a fluid filled cavity 
that is transformed to a blastocyst. The blastocyst has an inner and outer cell mass celled the 
embryoblast and thropoblast, respectively. The inner mass gives rise to the embryo while the 
outer mass is the source of the placenta (figure 1.5).  The blastocyst is released from the zona 
pellucida when the embryo reaches the uterus, and the embryo interacts with the 
endometrium for implantation (Jaroudi and SenGupta 2007). Spermatozoa with DNA 
damage may be capable of fertilizing an oocyte, however, development and survival of the 
embryo is highly related to integrity of the genetic material (Ahmadi and Ng 1999).  
 
Figure 1.5 Fertilization and development of the pre-implantation embryo(modified from Jaroudi and 
SenGupta2007). 
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1.5 In vitro fertilisation (IVF) 
In vitro fertilisation (IVF) is fertilisation of oocytes by sperm cells outside the body.  
The history of IVF dates back to experiments in the 1800 century with successful transfer of 
embryos from an oviduct in rabbit to the uterus in hare. The first successful completed IVF 
was carried out with rabbit oocytes in 1959 (Chang 1959; Zhao et al., 2011). Experiments 
with human strategies for IVF were improved, and in 1978 the first successful human test 
tube baby was born (Steptoe and Edwards 1978). The IVF technique is now well established 
and is applied for production of embryos to research experiments, treatment of human 
infertility, enhancing productivity of domestic animals and for conservation of endangered 
animals. IVF protocols are now available for most species, including mice, and can produce 
fertilized ova and viable offspring after transfer to recipient females (Bavister 2002).  
1.6 Polycyclic aromatic hydrocarbons with focus on Benzo(a)Pyrene 
1.6.1 Properties of BaP 
Benzo(a)pyrene (BaP) is a PAH in the class of benzopyrenes, which is composed of a 
benzene ring fused with a pyrene molecule. BaP consists of five benzene rings (C20H12) and 
have a molar mass of 252.31. The melting and boiling points are 179°C and 495°C 
respectively. BaP is lipophilic with a LogP of 6.19 and the estimated half lives are <1-6 days 
in the atmosphere, <1-8 hours in water, 5-10 years in sediment and >14-16 months in soil 
(Spectrum Laboratories 2000).  
The mutagenic and carcinogenic potential of BaP is caused by arrangement of the benzene 
rings in a bay region (figure 1.6). Carbon 9-12 is considered to be the bay region and carbon 
10 is regarded as an active centre (Miller and Ramos 2001). The bay region in BaP is a 
sterically hindered cup-shaped area. Thus, oxidation or radical formation occurs more easily, 
while detoxification and conjugation is impeded because of the bay region structure. Binding 
of an epoxide in this area makes BaP a diol epoxide, which is an ultimate carcinogen 
(Conney 1982; Dabestani and Ivanov 1999; Sims et al., 1974). The BaP molecule also 
contains a K-region in carbon 4 and 5, with high electron density and therefore high 
metabolic activity (Miller and Ramos 2001).   
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Figure 1.6 The structure of Benzo(a)pyrene (Miller and Ramos 2001) 
1.6.2 Occurrence and sources of PAH and BaP 
PAHs are formed during incomplete combustion of organic material at 300-600°C. Sources 
to PAHs are diesel engine emission, automobile exhaust, cigarette smoke, oil and coal, 
smoke formed by heating with wood and fried food (Boffetta et al., 1997; Boström et al., 
2002; Lewtas 2007). A part of the PAHs in the atmosphere also arises from natural 
combustion in forest fires and volcanic eruptions (Nikolaou et al., 1984). During the past 
centuries, especially in industrialised countries, the occurrence and emission of PAHs have 
increased dramatically. This development is due to the abundant use of fuels for industrial 
applications, heating, transport and many other purposes, and as a consequence, the levels of 
PAHs in cities are higher than in rural areas. The total quantity of PAHs in the environment 
is not easy to measure due to various sources, mixtures and differences between areas. The 
most significant source of PAHs in countries like United States and Sweden is residential 
burning of wood. In the cities however, working machinery and vehicle exhaust contributes 
to the major part of the PAH emission (Boström et al., 2002). PAHs are ubiquitous and 
genotoxic and are therefore a constant threat to the integrity of our genomes.  
BaP is the most well known and studied PAH (Boffetta et al., 1997; Jeffrey 1985; 
Verhofstad et al., 2011). There is no commercial production or use of BaP, but all the 
mentioned sources releases BaP to the air where it may bind to particular matter. Ultraviolet 
radiation may catalyse oxidation and degradation of PAHs, and give dry deposition to land 
and water (Boström et al., 2002). In the last 30 years, the levels of BaP in the air have 
decreased significantly. In 1960 the BaP levels in some European cities approached 100 
ng/m
3
. Today the concentrations in Europe are often below 1 ng/m
3
 at background stations 
and between 1-5 ng/m
3
 in areas close to traffic (Boström et al., 2002). This development is 
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due to a reduction in the use of coal and open burning, and an increase in use of oil and 
natural gas energy sources ,as well as improved combustion technology (Baek et al., 1991).  
1.7 Metabolism of BaP 
1.7.1 Bioactivation 
Xenobiotics including PAHs are often hydrophobic and non-polar and may accumulate in 
cells because the environment is more hydrophilic. Metabolism of PAHs occurs in general in 
all tissues of the human body, with liver as the main organ for bioactivation due to the high 
amount of required enzymes. The large cytochrome p450 (CYP) family together with several 
other enzymes participate in the metabolism (Conney 1982; Kemper et al., 2008). Phase I 
enzymes for metabolism of BaP includes several CYP p450 enzymes, epoxide reductase 
(ER) and epoxide hydratase (EH). Primary metabolites of BaP are epoxides, dihydrodiols, 
phenols, and quinones (Gelboin 1980; Selkirk 1977). Phase II conjugating enzymes includes 
glutathione-S-transferases (GST), UDP-glucurosyltransferases (UGT) and sulfotransferases 
(SULT) (Gelboin1980). Secondary metabolites of BaP are formed following further 
enzymatic attack of primary metabolites, and the enzymes can react with available hydrogen 
molecules in BaP. Both phase I and phase II enzymes have the purpose of altering BaP to 
intermediates with higher hydrophilicity, for easier elimination from the organism. BaP is 
metabolised to numerous metabolites, with three main pathways for bioactivation as 
reviewed by Xue and Warshawsky in 2005. 
In BaP, the bay region dihydrodiol epoxide pathway starts when oxygen is introduced at a 
double bond by CYP1A1/ 1A2/1B1 and creates BaP-7,8-oxide. Hydrolysis of BaP-7,8-oxide 
by epoxide hydrolase (EH) generates BaP-7,8-dihydroxy-7, 8-dihydrodiol (BaP-7,8-diol). 
Another CYP mediated oxidation at the double bond next to the diol group generates BaP-
7,8-dihydroxy-9,10-epoxid (BaP-7,8-diol-9,10-epoxide, BPDE) (figure 1.7). BPDE can react 
and from stable adducts in the DNA (Conney 1982; Sims et al., 1974; Xue and Warshawsky 
2005). Of all primary and secondary metabolites of BaP, the diol epoxides are the most 
mutagenic, cell-transforming, and carcinogenic metabolites (Pelkonen and Nebert 1982). 
Four isomeric BaP-7,8-diol-9,10-epoxides (± anti and ± syn) may be formed during 
activation of BaP (Baird et al., 2005). The (+) anti-BPDE isomer is referred to as an ultimate 
carcinogen, and it is also the most abundant of the four isomers (Takemura et al., 2010; Xue 
and Warshawsky 2005).  
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In the radical cation pathway peroxidase activity of CYP forms a BaP radical cation in a one-
electron mediated oxidation (figure 1.7). The radical cations are electrophilic and have 
potential to interact with nucleophilic cores in cellular macromolecules like DNA. The 
electrophilic charge is generally localised at carbon 6 and 10 in BaP (Xue and Warshawsky 
2005).  
Reactive PAH-ortho-quinones may be formed when dihydrodiol dehydrogenase (DD) from 
the aldo-keto-reductase family (AKRs) competes with the CYP-enzymes and oxidise BaP-
dihydrodiols (Penning 2004). The reaction is NADP
+
 dependent, and forms a ketol that 
spontaneously rearrange to an unstable catecol, and becomes an electrophilic o-quinone by 
auto-oxidation (Smithgall et al., 1988). The o-quinones can be reduced to catecol again or 
they might form oxidative DNA adducts. Auto-oxidation subsequently generates radicals 
due to the redox cycle that generates reactive oxygen species (ROS) multiple times (Penning 
2004; Xue and Warshawsky 2005). Quinone formation can account for a large metabolic 
yield of BaP in a variety of tissues (Lesko and Lorentzen 1985).  
 
Figure 1.7 Pathways for BaP-induced DNA-adduct formation. BaP can form radical cations by one-electron 
mediated oxidation that produce adducts at position N7 and C8 in guanine. Toxic quinones may form the 
common 8-OHdG adduct, which may be transferred to 8-oxoG. The bioactivation of BaP to the reactive 
metabolite BPDE may form DNA-adducts, including BPDE-N
2
-dG or BPDE-N7Gua (Godschalk et al., 2003).  
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CYP1A1/1A2/1B1 enzymes are induced through the aryl hydrocarbon receptor (AhR) 
pathway. BaP binds to AhR in the cytoplasm of cells, which changes the receptors 
configuration and mediates active transport into the nuclei. AhR associates with Ah nuclear 
translocator protein (ARNT), and the complex binds to a xenobiotic response element (XRE) 
in the DNA which induces enhanced transcription of genes for the CYP enzymes (Kemper et 
al., 2008; Takemura et al., 2010; Tarantini et al., 2011).  
1.7.2 Detoxification 
Despite formation of  potentially damaging intermediates that may promote cellular injury 
and toxicity,  the purpose of oxidative metabolism of BaP is detoxification and elimination 
from the body (Roth and Vinegar 1990). The conjugating phase II enzymes attach functional 
groups to parts of the BaP molecule to increase their hydrophilic character. The initial 
metabolism of BaP through the CYP p450 monooxygenase system generates several oxide 
intermediates, including 7,8-oxide. These oxides can rearrange spontaneously to phenols, be 
hydrolysed to trans-dihydrodiols or react covalently with glutathione either spontaneously or 
catalysed by glutathione-S-transferases. Phenols, quinones and dihydrodiols can be 
conjugated to water-soluble compounds by either sulphation or glucuronidation 
(Gelboin1980). BaP phenols are the preferred substrates for UDP-glucuronyl transferases. 
Glutathione, glucuronide and sulphate conjugates are formed both in vitro and in vivo and 
glutathione conjugations are the most important pathway for detoxification of BaP. 
Excretion through hepatobiliary route and faeces is the most important route for elimination 
(Plummer et al., 1980).  
1.8 Human exposure and toxicokinetics of BaP 
Humans may be exposed to BaP via inhalation, oral intake through the gastrointestinal (GI) 
tract or dermally through the skin (Boffetta et al., 1997; Boström et al., 2002). These 
pathways give a distribution of BaP throughout the body, dependent on the administered 
route. PAHs including BaP generally enter lipophilic tissue in the body. BaP can pass over 
plasma membranes in cells due to its lipophilic properties, and associate with hydrophobic 
molecules that may distribute BaP throughout intracellular compartments (Miller and Ramos 
2001). BaP tend to be accumulated in the kidneys, liver, and fatty tissue while smaller 
amounts are stored in the spleen, adrenal glands, and ovaries. The excretion depends on the 
route of administration, but is generally rapid within a few days (ATSDR 1995). The highest 
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non-occupational intake of BaP is through diet and represents for non-smokers 70 % of the 
total BaP-exposure (Phillips 1999).  
BaP present in the air are usually bound to particles. The pulmonary absorption of BaP is 
therefore influenced by the solubility of the carrier particles. Inhaled PAHs may be absorbed 
via the mucous lining of the bronchi in lungs (ATSDR 1995). After inhalation of a single 
dose BaP (1µg/kg) in rats, 21 % was available in the liver within 10 minutes (Weyand and 
Bevan 1986). BaP inhalation in rats give high levels in the lungs, liver, kidney, 
gastrointestinal tract, esophagus, small intestine and blood (Sun et al., 1982). Generally, 
liver and bile is the major elimination route of PAHs in animals following inhalation 
exposure (ATSDR 1995).  
Humans may be exposed to BaP orally by intake of fried and charcoal-grilled food, 
contaminated vegetables and crops, and contaminated drinking water (Boström et al., 2002).  
Absorption of substances after oral intake in humans is dependent on lipophilicity of the 
compounds. Ingested PAHs may be absorbed in the GI in fat-soluble compounds.  
Absorption of BaP following ingestion is relatively low in humans (ATSDR 1995). BaP is 
distributed to the liver, lung, and kidneys after oral administration (Yamazaki et al., 1987). 
In a study with oral exposure to BaP (1µg BaP/kg) in rats there was some evidence of 
enterohepatic recirculation. Six hours after exposure, 53 % of the administered dose was 
excretes into intestine contents of the animals lacking a bile cannula. 77 % of the 
administated dose was recovered in bile, intestines and intestine contents of animals with a 
bile cannula over the same period (Weyand and Bevan 1986). After oral BaP-exposure in 
rats, elimination via faeces dominates in early excretion and urinary route dominates later 
(Ramesh et al., 2001). 
Dermal exposure to BaP can occur through contact with soil that contains high levels of the 
toxicant, including petroleum products like soot and tars. Dermal absorption of PAHs 
appears to be rapid in both humans and animals, however, the extent of absorption is 
variable and affected by the vehicle used for administration. Dermal absorption occurs 
through passive diffusion (ATSDR 1995). Elimination of BaP after percutaneous exposure 
in rats occurs relatively rapid in the urine and faeces (Yang et al., 1989).  
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1.9 Toxicity 
BaP toxicity is mediated by the reactive intermediates formed by oxidative metabolism. 
These intermediates may react with macromolecules in cells and give structural and 
functional alterations (Miller and Ramos 2001). The acute and sub-chronic toxic effects of 
BaP are relatively low. LDLO (lethal dose low) for mouse after intraperitoneal (i.p.) 
administration is 500 mg/kg bodyweight (Epstein et al., 1972). However, the chronic effects 
from low doses of BaP are of great concern. BaP toxicity may occur in cells (cytotoxicity), 
immune system, liver, hematopoietic system, the reproductive system and kidneys. A study 
has indicated that male rats are more sensitive for damage than female rats (ATSDR 1995; 
Knuckles et al., 2001). Inhalation of BaP may result in toxicity of the respiratory tract and 
lungs (ATSDR 1995).  
1.10 Reproductive toxicity 
BaP have potential to affect the reproductive system in both males and females. Exposure to 
BaP in mice is linked with early ovarian failure, destruction of oocytes and reduced fertility 
(Mattison et al., 1980). A study with administration of BaP by gavage in mice for ten days 
during gestation gave a reduced percentage of females able to bring forth progeny at the 
highest dose tested (160 mg/kg bw/day). The lowest dose tested (10 mg/kg bw/day) also 
gave reduced fertility, associated with alterations in gonadal morphology and germ cell 
development. Treatment with higher doses resulted in total sterility (MacKenzie and 
Angevine 1981).  
The spermatogenesis in males may be susceptible for damage by toxicants in mitotic 
spermatogonia, meiotic germ cells, post meiotic spermatids and spermatozoa under 
maturation in the epididymis. This may affect the production and integrity of the mature 
sperm, and both double and single stranded breaks may occur in the DNA (Ahmadi and Ng 
1999; Delbes et al., 2010). BaP-exposure to sperm cells give rise to bulky DNA adducts and 
potential transfer of these to embryonal DNA following fertilisation. In smoking couples, the 
amount of BaP related DNA-adducts in the embryo seemed more dependent on paternal than 
maternal smoking (Zenzes et al., 1999b). Smoking also has a dose related association to low 
quality of spermatozoa (Ahmadi and Ng 1999; Vine 1996). DNA integrity of sperm cells is 
essential for fertilisation and normal embryonal development (Barratt et al., 2010; Gaspari et 
al., 2003). Dominant lethality studies of mice may be performed for evaluation of 
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reproductive toxicity (Epstein et al., 1972; Generoso et al., 1982). Exposure of male mice to 
a high dose of BaP resulted in dominant lethal effects, indicated by a decreased number of 
living embryos due to high incidents of pre and post implantation losses (Generoso et al., 
1982; Shukla and Taneja 2001).   
1.11 Carcinogenesis 
BaP is referred to as a pro-carcinogen and requires metabolic activation to become 
carcinogenic (Conney 1982). BaP is known as a complete carcinogen because it can 
facilitate carcinogenesis via its own metabolism (Baird et al., 2005). Previously BaP was 
placed in group 2B (possible carcinogenic to humans) on the list from International Agency 
for Research on Cancer (IARC), but extensive research have moved BaP to group 1 
(carcinogenic to humans) (IARC 2011; Takemura et al., 2010).  
In the early 1900s it became generally known that soot, coal and tar are carcinogenic to 
humans. Experiments with rabbits in 1915 proved carcinogenicity when this PAH containing 
material caused tumours at the site of application. In the early 1930, BaP was shown to cause 
tumours in rodents, and the use of BaP as a model for PAHs originates from this observation 
(Boström et al., 2002). Since then there has been a substantial number of studies on BaP and 
its carcinogenic potential. BaP produce tumours in experimental animals after administration 
via oral, skin and intratracheal routes. The carcinogenic effects of BaP are both local and 
systemic, and has shown to be carcinogenic in  single-dose experiments (IARC 1973). 
Exposure to BaP is believed to cause tumours in a diverse range of human tissue, including 
lungs, skin, esophagus and colon, pancreas, bladder and breasts in woman. The effect is 
dependent on exposure route (Boström et al., 2002). Lung tumours have been identified 
following inhalation, i.p. injection and oral administration in rats. Oral exposure to BaP also 
induces stomach tumours while skin tumours have been observed after topically 
administration (Qu and Stacey 1996). The most significant health effect caused by inhalation 
of BaP in humans is lung cancer (Boffetta et al., 1997; Nielsen et al., 1996; Qu and Stacey 
1996).  
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1.12 DNA damage 
DNA damage is alteration of the genetic material in cells, and the main contributing factor to 
mutagenesis, carcinogenesis and aging. DNA damage may arise from exposure to exogenous 
agents like radiation and chemicals or be the result of metabolic endogenous processes. 
Hydrolysis and generation of ROS or reactive metabolites may all generate DNA damage in 
cells (De Bont and van Larebeke 2004). BaP have the potential to cause DNA damage in 
both somatic cells and germ cells. Several metabolites of BaP may form DNA-adducts and 
give mutagenic and carcinogenic effects if not repaired. The ability for reaction with DNA 
could be influenced by the availability of detoxifying enzymes like glutathione (Jeffrey 
1985). However, many of the BaP metabolites manage to escape defence mechanisms, and 
generate DNA adducts immediately after metabolism.  
As described in chapter 1.7.1, the BaP metabolite BaP-7,8-diol-9,10-epoxide (BPDE) has 
proven to be the most tumorgenic metabolite (Conney 1982; Takemura et al., 2010; Xue and 
Warshawsky 2005). The epoxide group in the bay-region makes the epoxide resistant for 
hydrolysation by epoxide hydrolase, and susceptible for nucleophilic attack. BPDE-DNA 
adducts occur primarily through covalent linkage of carbon 10 at the epoxide and the amino 
groups of deoxyadenosine and deoxyguanosine DNA residues (Szeliga and Dipple 1998). 
The major part of the epoxides forms guanine residues at the N
2
 position of guanine and 
produces N
2
-deoxyguanosine(dG)adducts (BPDE-N
2
-dG) (Chary et al., 1995). Several of the 
BaP metabolites have genotoxic properties, including semiquinone intermediates formed 
during redox-cycling of quinones which can bind directly to the DNA. BaP-quinone 
metabolites can also form unstable DNA adducts. These and generation of ROS during 
metabolism, may induce oxidative DNA damage (Devanesan et al., 1996; Miller and Ramos 
2001). Figure 1.7 shows some of the pathways for formation of BaP-induced DNA adducts. 
A relatively high dose of coal tar (0.2 g/100g meal) over a time period of 28 days, give 
detectable BPDE-N
2
-dG adducts in the liver, lung, and fore stomach of mice. The highest 
amount of adducts were present in the liver (Culp and Beland 1994). BPDE-DNA adducts 
were also present in lungs, liver, spleen and peripheral blood in rats after i.p. injections of 10 
mg/kg bw BaP three times a week for two weeks. The highest amount of adducts were 
present in the lungs (Qu and Stacey 1996). This indicates that the administration route of 
BaP has influence on absorption and toxicity. There may be various consequences of an 
increased amount of BPDE-DNA adducts in cells. Commonly the outcome is mutations that 
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alter the integrity of the genome. The male germ cells are target for BaP metabolites. 
Smoking men have a higher degree of DNA adducts, including BPDE, in their sperm DNA 
compared to non-smoking men (Zenzes et al., 1999a), and this may be a link to a reduced 
fertility observed in smoking men (Vine 1996; Zenzes et al., 1999a). The reduced fertility 
can also be caused by abnormal protamine expression, excessive generation of reactive 
oxygen species (ROS) and abortive apoptosis during spermatogenesis (Barratt et al., 2010). 
Genotoxic environmental mutagens are also a serious threat to the DNA integrity of somatic 
cells (Peruzzi et al., 2010).  
1.12.1 Reactive oxygen species 
Oxidative stress is a condition where an increased rate of cellular damage occurs, induced by 
oxygen or oxygen-derived oxidants (ROS). A background level of oxidative stress are 
normal in cells, however, this level may be amplified by chronic disease stages, aging or 
toxin exposure. ROS are generated in cells by external factors or internal metabolic and 
biochemical reactions, and are highly reactive and oxidising agents in the class of free 
radicals. The most common types of ROS are superoxide (O2
-
), hydrogen peroxide (H2O2), 
hydroxyl radicals (OH
•
) and singlet oxygen (
1
O2) which all have the ability to oxidise the 
DNA (De Bont and van Larebeke 2004; Halliwell 1991; Miller and Ramos 2001; Sikka et 
al., 1995). ROS may generate genotoxic oxidative DNA damage including oxidised bases 
and single or double stranded breaks in the DNA. Damage may also occur in proteins and 
lipids and ROS mediated cellular DNA damage is the most common type of damage in cells 
(De Bont and van Larebeke 2004). The mitochondria consume most of the cells oxygen in 
production of adenosine triphospate (ATP), and a high flux of radicals is generated with 
potential for creating DNA damage (Richter et al., 1988; Richter 1995). Mitochondria may 
be cellular targets of BaP. Cytotoxicity from BaP-quinone is observed with a decrease in 
cellular ATP content. This induce mitochondrial morphological changes which can create 
loss of cell survival (Zhu et al., 1995).  
Guanine has low energetic properties and is therefore the most vulnerable base for oxidative 
attack from radicals, and the most common mutagenic lesion formed by oxidative stress is 
7,8-dihydro-8-oxoguanine (8-oxoG) (figure 1.8). This oxidised guanine base have mutagenic 
and miscoding properties (Cheng et al., 1992; Larsen et al., 2004). In rats exposed to BaP, 
an increased level of oxidative damage like 8-OhdG were observed in the liver, kidneys and 
lungs (Kim and Lee 1997), and sperm cells with enhanced levels of 8-oxoG has shown 
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correlation with decreased sperm concentration in humans (Ni et al., 1997). It is unclear 
whether BaP-exposure induces oxidative DNA-lesions in sperm. However, as mentioned in 
chapter 1.13, a transgenic mouse (Ogg1
-/-
) is used by the Department of Chemical 
Toxicology (MIKT) as a model for human toxicological responses in the testis.  
 
Figure 1.8 Formation of 7,8-dihydro-8-oxoguanine (8-oxoG) (modified from Wells et al., 2009). 
1.13 Repair of BaP-induced DNA lesions in testicular cells 
Repair systems are present in all cell types of the human body. DNA repair is necessary for 
survival, although some mutations are essential for evolution. The constant DNA damage 
provided by endogenous and exogenous sources requires constant replacement of damaged 
nucleotide residues. Repair of common DNA lesions lower the potential for mutagenic and 
cytotoxic events, although the DNA repair pathways are not absolutely exact. On of the main 
pathways for DNA repair is base excision repair (BER). BER normally repairs common 
DNA lesions caused by exogenous and endogenous agents, including ROS-induced DNA 
lesions like 8-oxoG. Nucleotide excision repair (NER) mainly repair helix-disorting damage 
caused by environmental mutagens, including bulky BPDE-DNA adducts. NER recognise 
altered DNA lesions and makes an incision of the DNA strand containing the lesion. DNA 
synthesis and ligation replaces the deleted oligo-nucleotide (Lindahl and Wood 1999; Olsen 
et al., 2005).    
The population of stem cells in testis is under a constant attack from DNA damaging agents 
through the whole adult life. A repair system is necessary for removal of DNA lesions that 
are induced every day, and for removal of the high level of mutations that otherwise could be 
transferred to the zygote (Olsen et al., 2005; Sipinen et al., 2010). The different stages of 
spermatogenesis have different capacity for removal of DNA adducts. Removal of DNA-
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lesions in elongated spermatozoa is generally low due to the condensed chromatin in sperm 
cells, and removal of BPDE-N
2
-dG following BaP-exposure is poor in meiotic and post-
meiotic stages. When differentiating spermatogonia is exposed to BaP, these adducts does 
not persist to the spermatozoa stage, indicating a higher repair capacity in early stages (Olsen 
et al., 2010). However, a successful fertilisation and further embryonal development is 
dependent on the level of DNA damage in sperm, and the oocytes ability to repair DNA 
damage. Damage above a certain level may result in fragmentation of embryos or a low rate 
of embryonal development (Ahmadi and Ng 1999).  
Differences in repair capacity are observed between rodents and humans. This includes the 
8-oxoG lesions, where humans exhibit a lower capacity of repair than mice (Olsen et al., 
2003). Such differences are important to consider when evaluating results from animal 
experiments. Eukaryotic cells use a specific DNA glycosylase, a product of the OGG1 gene, 
to excise 8-oxoG from DNA (Klungland et al., 1999). A transgenic mouse model with 
destruction of the murine OGG1 gene for the DNA glycosylase, generates homozygous 
Ogg1
 
null mice (Ogg1
-/-
) for repair of this lesion. The Ogg1
-/-
 mice accumulate an increased 
level of 8-oxoG in the genome. (Klungland et al., 1999) These mice are viable and fertile, 
and show only a moderate increase in spontaneous mutations in the liver. This was not 
observed in the testis, and the mice show no striking pathological alterations (Klungland et 
al., 1999). Due to the decreased repair capacity, the testicular cells in Ogg1
-/-
 mice may have 
a more similar capacity to humans than Ogg1
+/+ 
mice. This is valuable when studying 
genotoxic effects from environmental mutagens in male germ cells.  
1.14 Methods for measuring DNA damage in sperm cells 
Studies have shown that increased sperm DNA fragmentation is associated with reduced 
fertility potential (Ahmadi and Ng 1999; Delbes et al., 2010). There are several methods 
available for measuring such DNA damage in sperm cells. The in situ nick translation assay 
applies fluorescence microscopy to quantify the insertion of marked nucleotides at single 
stranded DNA breaks in a reaction catalyzed by a template dependent enzyme. The Terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay uses another enzyme 
to recognize the same incorporation in double stranded DNA. The latter method can be 
applied in both fluorescence microscopy and flow cytometry. The Single Cell Gel 
Electrophoresis (Comet) assay is applied to a great extent at the MIKT-lab, and a modified 
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version quantifies single or double stranded DNA breaks in sperm DNA. This is achieved by 
single cell electrophoresis of spermatozoa stained with a fluorescent DNA binding dye 
(Barratt et al., 2010; Erenpreiss et al., 2006).  
The sperm chromatin structure assay (SCSA) assay is used in the present study, and is a well 
established and standardised method for examining chromatin integrity in sperm cells. The 
SCSA has been applied for both research and clinical use as a male fertility assay. The 
increasing use of assisted conception requires analysis of DNA integrity and a test like the 
SCSA is therefore valuable for human fertility assistance. The method is based on flow 
cytometry and is a technique used for both rodent and human samples (Evenson and Jost 
2000; Evenson et al., 1980). Results with toxicants have shown a high dose-response 
relationship and the SCSA results have been well repeatable. The principle for the SCSA is 
the extent of denaturation of sperm DNA after a short lasting acid treatment in situ. The 
denaturation occurs preferentially at sites of pre-existing DNA strand breaks. The sperm 
cells are stained with acridine orange (AO) to detect green fluorescence as a measure of 
intact double stranded DNA, and red fluorescence as a measure of denatured DNA (Evenson 
and Jost 2000). Each of the mentioned techniques for measuring sperm chromatin integrity 
has advantages and limitations. However, they give no or little information as to the nature 
of the DNA-damage.  
1.15 Pig-a assay for measuring somatic mutations in vivo 
Identification of human genotoxic compounds is an important step in risk assessment of 
chemicals. Generally, somatic genotoxicity compounds are assumed to be genotoxic also to 
male germ cells if the active metabolite can reach the testis. It is of interest to know to what 
degree mutagenicity in somatic cells are predictive for germ cell mutagenicity. The Pig-a 
assay is a relatively new and promising method that is developed for quantifying somatic 
mutations in vivo (Bryce et al., 2008). The Pig-a assay is best established and described 
using blood samples in rat (Miura et al., 2008; Phonethepswath et al., 2010), although the 
assay is also used for analysing blood samples in mice (Phonethepswath et al., 2008). PIG-A 
(phosphatidylinositol glycan, Class A) is a gene located on the X-chromosome. The gene 
product is a catalytic subunit with a central role in initial biosynthesis of 
glycosylphosphatidyl inositol (GPI)-anchors (Kawagoe et al., 1994). GPI-anchors are 
important glycolipids that attach membrane proteins on the cell surface. This is achieved by 
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a phospholipid tail attached in the cytoplasmic membrane and a short glycan structure that 
extend out in the extracellular environment. These anchors attach membrane proteins in a 
covalent binding (Dobrovolsky et al., 2010; Low 1989).  
There are several genes that influence the GPI-anchor synthesis, however, PIG-A is believed 
to be the only one of these that is located on the X-chromosome. Thus, only a single copy of 
the PIG-A gene is active in somatic cells. Only one mutation in this gene can restrain the 
synthesis of the GPI-anchors, with the consequence that the cell is unable to attach different 
surface proteins that relay on GPI (Dobrovolsky et al., 2010). This has created the 
hypothesis that absence of the GPI-anchor is a phenotypic marker for a mutation in the PIG-
A gene (figure 1.9) (Dobrovolsky et al., 2010; Phonethepswath et al., 2008). By using a 
fluorophore labelled antibody towards one of the surface proteins that relay on the GPI-
anchor, a mutation in the PIG-A gene can be recognised as cells that are unable to attach the 
antibody. PIG-A mutations in human cells is believed to be linked with the hematopoietic 
disease Paroxysmal nocturnal hemoglobinuria (PNH). Patients with this acquired disease 
have an abnormal population of blood cells, due to a deficiency in the GPI-anchor synthesis 
caused by a mutation in the PIG-A gene (Takeda et al., 1993).  
 
Figure 1.9 Schematic illustrations of rat cells with and without a mutation in the Pig-a gene. The cell to the left 
has a functional PIG-A gene, and is therefore able to express the surface protein CD59. The cell to the right 
have a mutation in the PIG-A gene with the consequence of a deficient GPI-anchor, that are unable to attach 
CD59 on the cell surface (Bryce et al., 2008) 
Human blood consists of reticulocytes, mature erythrocytes and leukocytes suspended in 
plasma which is composed mainly of water, ions, glucose, hormones and thrombocytes 
(platelets) (Vander et al., 2001a). Red blood cells, white blood cells and platelets are 
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continuously renewed in the bone marrow from the hematopoietic stem cells. Stem cells 
form populations of multipotent progenitor cells that give rise to the major cell lines in the 
bone marrow, which are erythroid, myeloid, megakaryocytic and lymphoid (Riley et al., 
2001). Reticulocytes (RETs) are immature red blood cells. They are anuclear and slightly 
larger than mature red blood cells (RBCs). The youngest RETs in the bone marrow have a 
dense mass of RNA, mitochondria, ribosomes, centriole and remnants of the Golgi 
apparatus. These cellular organelles are progressively lost during maturation together with 
ability of hemoglobin synthesis (Gasko and Danon 1974). After normally 2 days in the bone 
marrow the RETs are released into the peripheral blood stream and undergo final maturation. 
The RNA becomes less dense and only scattered remnants of RNA remains in the most 
mature RETs and this is also lost when they becomes mature RBCs. RETs becomes mature 
RBCs after about three days in the peripheral blood. The number and character of RETs in 
the blood stream reflects the activity of the bone marrow (Gasko and Danon 1974; Geminard 
et al., 2002; Patel and Lodish 1984; Riley et al., 2001). Red blood cells isolated from whole 
blood in mice were used in the present master thesis for evaluation of mutation load in 
somatic cells by the Pig-a assay. The aim is to relate mutation frequency in somatic and 
germ cells following BaP-exposure in mice. However, as the technique is new, N-ethyl-N-
nitrosourea (ENU) was used as a positive control (chapter 1.15.1).  
1.15.1 N-ethyl-N-nitrosurea (ENU) 
N-ethyl-N-nitrosourea (ENU) is a laboratory-synthesised compound with the highest 
mutation rate of any germ line mutagen tested in mice (figure 1.10). It causes random single 
base pair mutations in a wide variety of organisms. ENU acts directly through alkylation of 
nucleic acids without need for any metabolic activation. The compound has an ethyl group 
that can be transferred to oxygen or nitrogen radicals in several reactive sites identified both 
in vivo and in vitro. These transferred groups of ethyl causes DNA adducts, which may give 
miss pairing  during DNA replication (Noveroske et al., 2000). ENU is a strong mutagen 
with fairly cytotoxic effects (Goth-Goldstein and John Burki 1980). 
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Figure 1.10 N-ethyl-N-nitrosourea (ENU) with an ethyl group (Noveroske et al., 2000). 
1.16 Mouse as a model organism 
Effects of drugs and chemicals are to a large extent based on extrapolation from animal data, 
and animal studies are essential to our understanding of basic biological mechanisms and 
disruption in human key processes (Barratt et al., 2010). The field of reproduction is well 
studied and crucial time spots and appearance of the different stages of sperm cell 
development is well defined (Bellve et al., 1977; Borg et al., 2010). Mice are widely used in 
reproduction studies for several reasons. Experiments in mice are possible to conduct after a 
relatively short time period and a great number of genes are also conserved between man and 
mouse. Mice are also relatively cheap to house and the use of transgenic mouse lines are of 
great advantage. However, there are great differences between man and mice and results 
from animals studies must be handled with caution and cannot be directly transferred to 
humans. In the present master, the Ogg1
-/-
 mouse has been used as a model for BaP effects in 
human testicular cells.  
1.17 Aims 
The overall goal in the present work has been to study the role of environmental mutagens 
on male reproductive health. Exposure of male mice to BaP has been shown to reduce sperm 
quality and to induce an increase in pre- and post-implantation losses of embryos. We 
wanted to achieve a better understanding of the mechanisms responsible for male mediated 
reproductive toxicity of BaP and related environmental mutagens.  
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Specific aims: 
• Analyse effects of in vivo BaP-exposure of mice on sperm chromatin integrity 
Analyses of sperm DNA damage is a challenge due to the highly compact nature of 
sperm DNA. Analytic measurements have shown that BaP may induce sperm BPDE-
DNA adducts. We wanted to test whether the sperm chromatin structure assay (SCSA) 
was able to detect sperm DNA damage following BaP-exposure in mice. 
• Examine if Ogg1-/- mice are more sensitive to BaP-induced sperm DNA damage 
than Ogg1
+/+ 
mice 
The Ogg1
-/-
 mice are proposed as a model for human responses to testicular toxicants. 
SCSA results were used to compare the response of BaP-exposure in Ogg1
-/-
 mice to the 
response in wild type mice.  
• Examine if sperm BPDE-DNA adducts persist in mice embryo  
One study suggests that sperm BPDE-DNA adducts may persist past the first embryonal 
cell divisions (Zenzes et al., 1999b). We wanted to verify this finding in a mouse model 
when only the father was exposed to BaP.  
a) Set up an immunological method to detect cellular BPDE-DNA adducts. 
b) Establish a handling procedure for adduct detection in pre-implantation embryos. 
c) Immunological staining for BPDE-DNA adducts in two and four cell embryos.  
• Establish the Pig-a assay for analysis of in vivo induction of somatic mutations  
The Pig-a assay is currently characterised and optimised by the Litron Laboratories. One 
of the aims of this project was to set up the Pig-a assay at the Department of Chemical 
Toxicology (MIKT) lab. This included testing of the assays performance in mice 
exposed to the potent mutagen ENU in vivo.  
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2. Materials and methods 
All solutions and chemicals used in these experiments are listed in the Appendix. 
2.1 Mice 
2.1.1 Animals and genotypes 
In the BaP experiment, male Ogg1
+/+
 C57BL/6J BomTac mice obtained from Taconic in 
Ejby, Denmark were used together with C57BL/6 Ogg1
-/-
 mice. Ogg1
-/- 
mice were bred at 
the Norwegian Institute of Public Health (NIPH), Oslo, Norway as described in chapter 
2.1.2. The mice from Taconic acclimatised for a week after arrival. Two to five mice (9-11 
weeks) were housed per cage and individually marked by ear punching. Groups of 7-10 mice 
were treated with BaP, corn oil or remained untreated. All animals in the BaP-experiment 
were sacrificed ten days after exposure (chapter 2.2.1). Strains of Ogg1
+/+
 and Ogg1
-/- 
mice 
were a part of the experimental design, however, a mistake with the genotyping of animals 
occurred at the laboratory. This was first discovered after the experiment and many of the 
Ogg1
-/- 
animals were actually Ogg1
+/+
 or Ogg1
+/- 
(heterozygous).  
Male B6D2F1 (8-12 weeks) and female B6D2F1 (4-6 weeks) mice, both obtained from 
Charles River Laboratories were used in the in vitro fertilisation (IVF) experiments. 
C57BL/6J male mice obtained from Taconic in Ejby, Denmark were used in the Pig-a 
experiment. Random unexposed mice obtained from the NIPH, were used in 
immunostaining and Pig-a experiments when establishing and testing the procedures. 
2.1.2 Breeding and care 
Ogg1
-/- 
mice were housed in air flow IVC racks (Thoren Maxi-Miser System) and filter 
cabinets (Scantainer, Scanbur BK AS, Nittedal, Norway) in plastic disposable cages on 
Nestpack (Datesand Ltd., Manchester, UK) bedding. They were exposed to a 12/12 h 
light/dark cycle, 6-10 air changes per hour, room temperature (20 ± 2 °C) and controlled 
relative humidity (55±5 %). Diet and water were given ad libitum. The mice were given a 
breeding/maintenance diet (2018SX Teklad Global 18% Protein Extruded Rodent Diet, 
Harland Teklad, Madison, Wisconsin, USA). All research was performed in conformity with 
the laws and regulations for experiments with live animals in Norway.  
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2.2 Sacrificing animals, organ removal and sperm isolation 
2.2.1 BaP experiment 
Mice were sacrificed by CO2 gas when establishing a reference sample and a positive control 
for the sperm chromatin assay (SCSA). Due to animal welfare, cervical dislocation was used 
in all subsequently experiments. Epididymis and selected tissues was surgically removed 
from the male mice ten days after BaP-exposure, immediately frozen on dry ice and stored at 
-80°C. A chirurgic scissor was used to make an opening in cauda epididymis and a bended 
needle was used to put on gentle pressure to release sperm cells. The squeezing was 
performed in phosphate buffer (PBS), deoxyribonuclease (DNase) buffer or TNE buffer 
depending on the different experiments.  
2.2.2 In vitro ferilisation (IVF) 
Egg-clutches with 10-20 oocytes surrounded by cumulus cells were removed surgically from 
each oviduct in female mice and transferred to Eppendorf tubes with M2 medium before 
IVF. Cauda sperm for fertilisation were made available as described above (chapter 2.2.1).  
2.2.3 Pig-a experiments 
Blood was collected from mice in the Pig-a experiments. The saphenous vein was incised 
with a surgical blade and blood was transferred directly to heparin coated capillary tubes 
(size 400-600µl). For the experiment with platelets and lymphocytes, four mice was 
anesthetised by intraperitoneal (i.p.) injection (ZRF-coctail with Zoletil, Rompun and 
Fentanyl as used by the animal department at NIPH) and heart punctured with a heparin 
coated needle for draining of blood. Blood was transferred to heparin coated tubes (BD 
Vacutainer 13 x10 mm). Mice were sacrificed directly afterwards by cervical dislocation. 
Handling of animals was performed by trained personnel.  
2.3 Benzo(a)Pyrene 
2.3.1 Dissolving BaP in corn oil 
BaP is lipophilic and almost insoluble in water. Corn oil was therefore used as a solvent. 
BaP is toxic and carcinogenic and all the required precautions were taken. Hence, a 
ventilation cabinet, glows and a safety mask were used. 
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Procedure: 
1. A 100 mg vial of BaP was used. In a biohazard bench, BaP was transferred to a 
sterile glass Erlenmeyer flask, and corn oil was added to obtain a concentration of 7.5 
mg BaP/ml corn oil. 
2. The Erlenmeyer flask was placed in a water bath at 30°C with shaking for about 1 
hour to dissolve.   
3. Remaining undissolved material was dissolved by placing the Erlenmeyer flask with 
BaP on a magnetic stirrer for 1 hour. 
4. The BaP solution was transferred to a sterile glass vial and covered with aluminium 
foil to shield from light. The vial was stored in the dark at room temperature inside a 
dry and ventilated security cabinet.  
2.3.2 Exposure of mice to BaP 
BaP dissolved in corn oil (chapter 2.3.1) was administered to the male mice via i.p. injection 
by trained personnel. Mice weighted from 21-25 g and were injected with 0.4 – 0.5 ml BaP 
in corn oil. The mice were administered a single dose of 150 mg BaP/kg bodyweight (bw), 
or the vehicle (corn oil). One group of animals stayed untreated as an additional control.  
2.3.3 Exposure of mice to N-ethyl-N-nitrosurea (ENU) 
N-ethyl-N-nitrosourea (ENU) dissolved in PBS was administered to mice via i.p. injection 
by trained personnel as a positive control for the Pig-a assay. Mice were injected three times 
over a period of five days (day, 1, 3, 5) with single doses of 40 mg/kg bodyweight for each 
animal. The mice were administered a total dose of 120 mg/kg bodyweight, or the vehicle 
(solvent). Two animals stayed untreated as an additional control.  
2.4 Sperm chromatin structure assay (SCSA) 
The sperm chromatin structure assay (SCSA) was introduced by Evenson in 1980 as a 
method to determine sperm DNA integrity, and how sperm DNA damage is related to 
fertility (Evenson et al., 1980). The assay characterises irregular chromatin structure in 
sperm cells via increased susceptibility of DNA to acid induced denaturation in situ. The 
SCSA is a standardised procedure with a detailed protocol described by Evenson and Jost 
(Evenson and Jost 2000). Sperm samples isolated in TNE-buffer as described in 2.2.1 were 
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denaturised in 30 seconds with an acid-detergent treatment, and then coloured with acridine 
orange (AO) which is a DNA intercalating dye. AO stains both single and double stranded 
DNA. Green fluorescence indicates double stranded DNA (native), while red fluorescence 
marks the single stranded and damaged DNA (figure 2.1). The principle for SCSA is that 
sperm DNA that already contains nicks, due to for instance destructive agents, is more 
susceptible for denaturation than undamaged DNA and thus have a higher red and a reduced 
green fluorescence signal. Accurate denaturation time and optimal pH conditions is essential 
for correct and comparable results. BD FACSDiva software (v 6.1.2) for the flow cytometer 
was used to obtain all data and cytograms from sperm samples. The program FCS express (v 
3.00.0821) was used for handling and calculation of data.  
A cytogram of green versus red DNA fluorescence (figure 2.1) was used to measure sperm 
DNA quality. The parameter Alpha t is the relationship between red (ss DNA) and total 
green and red (ss + ds DNA) fluorescence. Alpha t was used to detect sperm cells with 
increased red fluorescence and separate these from the main population of cells. The 
percentage of sperm that falls outside this main population in a sample is called the DNA 
fragmentation index (% DFI), and represents cells with increased level of single stranded 
DNA. % High green represents cells with increased green fluorescence, and are shown to be 
cells with an incomplete chromatin condensation like that present in immature cells. Mean 
Alpha t, % DFI and % High green were parameters used for analysing the SCSA result.  
A reference sample with unexposed sperm cells was used in the assay before running the 
actual samples, as a calibration sample for the flow cytometer. A reference sample sets the 
red and green photomultiplier tube (PMT) voltage, to yield the same mean green and red 
fluorescence levels for each sample in the experiment and functioned as a standard to 
observe where a main population of untreated sperm cells was located. This was used to 
define gates in the cytogram that separated the main cell population from cells in the % DFI 
or % High green areas. In the preliminary SCSA experiments, the reference samples were 
made by sperm cells in caudas from two untreated mice. The cells were allocated in 
Eppendorf tubes and stored at -80°C. Sperm cells from three Ogg1
+/+
 untreated control 
animals were squeezed and pooled in 800 µl cold 1x TNE buffer and used as a reference 
sample in the BaP experiment. The reference samples were not used more than once and 
were not saved for more than 1 hour at 4°C.  
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A positive control with caudal sperm and a high dose of DNase was also prepared for the 
SCSA. DNase is a nuclease enzyme that catalyses the hydrolytic cleavage of phosphodiester 
linkages in the DNA backbone. The positive control was used to make sure that the 
denaturation and staining of DNA with AO worked. The positive control is not described in 
the original SCSA manual, but was included in the procedure by the MIKT-lab. Sperm cells 
from caudas in an untreated control mouse were squeezed (chapter 2.2.1) in DNase buffer 
with 1% Triton X-100 to permeabilize the cell membrane. DNase (200 U/ml) for degradation 
of DNA was added to the sperm cells and the cells were incubated at 37°C for 1 hour and 
then centrifuged (Eppendorf centrifuge 5810R) at 288 x g for 5 min. Supernatant was 
aspirated and the pellet was re-suspended in 1x TNE buffer. Samples were allocated in 
Eppendorf tubes and stored at -80°C. Figure 2.1 shows sperm cells in a reference sample and 
a positive control with images obtained by flow cytometry.  
 
Figure 2.1 SCSA cytograms (top) of a reference sample and a positive control. Green fluorescence on the y-
axis represents double stranded DNA and red fluorescence on the x-axis represents single stranded DNA. A 
gate is placed around the population of sperm cells to eliminate debris, and the upper gate is for detection of % 
High green. The two lower diagrams shows the Alpha t populations in the reference (left) and positive control 
(right). The red M2 line represents cells outside the normal population of cells, meaning cells with a higher 
mean value of Alpha t than observed in the reference sample.  
A dose-response analysis with DNase exposed sperm cells was performed to test the 
sensitivity of the different parameters measured. A dilution series with DNase in DNase 
buffer was prepared using the same protocol as the positive control, and mixed with sperm 
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cells from an untreated mouse. The samples were run through the flow cytometer in order of 
the most diluted sample first, to avoid contamination from DNase in the more concentrated 
samples. Table 2.1 shows the different concentrations for the dilution series with DNase that 
were mixed with sperm cells in DNase buffer. 
Table 2.1 Concentrations of DNase (U/ml) in the dose-response experiment with sperm cells. 
Sample DNase (U/ml) 
a 0 
b 0.2 
c 2 
d 20 
e 200 
 
Sperm cells from BaP exposed, vehicle (corn oil) and unexposed animals were analysed by 
the SCSA to study if the treatment groups showed any difference in degree of DNA damage. 
SCSA procedure: 
1. The flow cytometer (BD LSRII) was prepared: 
a) Lasers in the cytometer needed 20 min for warming up. 
b) A test tube containing ddH20 was run through the cytometer. 
c) A standard solution with 350 µl PBS and roughly two drops of BDTM cytometer 
setup and Tracking beads (Lot id 66656) was run through the cytometer to quality 
check the laser settings. The rate was set at approximately 100 events pr. second. 
d) The cytometer needed adjustments before SCSA analysis: 
- The blue laser (488, 10-30 mW) was used for excitation 
- Emission is detected through filter (630-650 nm) for red fluorescence (ss 
DNA) and filter (515-530 nm) for green fluorescence (ds DNA). 
2. A test tube with AO equilibration buffer (400µl acid-detergent solution and 1.2 ml AO 
colour solution) was run through the cytometer for 15 min. Since AO is toxic, 
precautions when handling the solutions were needed. 
3. 200 µl from the reference sample with sperm from three pooled Ogg1+/+ control mice 
was transferred to a cold test tube and 400 µl cold acid-detergent solution was added and 
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mixed carefully. After exact 30 seconds, 1.2 ml cold AO staining solution was added to 
the tube and after 3 min the sample was run through the cytometer. 
4. The event rate was set at approximately 200 cells pr. second and the PMT were adjusted 
to the right voltage. The sperm population in the reference sample was used to make a 
gate for excluding debris and gates for detection of cells in the High green area. Number 
of cells counted for each sample was 10 000.  
5. A test tube with AO equilibration buffer was run through the cytometer before the first 
sample.  
6. Caudas were collected from the freezer and brought to the laboratory on dry ice. Sperm 
cells were squeezed on a cold plate in a petri dish with 800 µl cold TNE buffer for each 
cauda, immediately before flow cytometric analysis. The sperm cells in buffer were 
transferred to Eppendorf tubes through a filter for removal of cell lumps and debris.  
7. 200 µl of the sperm samples was transferred to a cold test tube and 400 µl cold acid-
detergent solution was added and mixed carefully. After exact 30 seconds, 1.2 ml cold 
AO staining solution was transferred to the tube and the samples were run through the 
cytometer. Data was recorded 3 min after adding the acid-detergent.  
8. A test tube with AO equilibration buffer was run through the cytometer between all 
samples to maintain AO equilibration conditions in the instrument and to flush the 
previous sample.  
2.5 In vitro fertilisation (IVF) in mice 
The In vitro fertilisation (IVF) procedure described in the present project is well established 
in mice (Nagy et al., 2003). We used IVF for generation of embryos to the immunostaining 
experiments. Sperm cells from BaP exposed male mice in vivo were used to fertilise oocytes 
from unexposed female mice. Embryos could then be inspected for BPDE-DNA adducts to 
examine if paternal BaP-exposure gave detectable adducts in embryonal DNA. Occurrence 
of BPDE-DNA adducts in the one, two and four cell stages of the embryo should be 
examined. The female mice went through a super ovulation procedure to induce maturation 
and increase the number of released oocytes. The males were exposed to BaP by i.p. 
injections (chapter 2.3.2) 4 days before IVF. A light microscope was used for visualisation 
of sperm and oocytes, and cells were handled on a heating block at 37ºC. A cell incubator 
was used for culturing of cells to maintain optimal conditions. The oocytes and embryos 
were transferred by using a mouth pipette with a thin glass tip. Oocytes from one side of the 
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female were mixed with sperm from BaP exposed males, while oocytes from the other side 
were combined with sperm from unexposed males. This assures that oocytes from all the 
females are present in both BaP exposed group and control group. IVF was accomplished 
with help from trained personnel at the MIKT-lab. This part of the experiment was 
performed as a part of a larger post doc project (Asgeir Brevik), and the embryos were also 
used in gene expression studies. Although the fertilisation and development of embryos was 
successful, we experienced some challenges with immunostaining of these embryos.  
IVF procedure: 
1. Day 4 before IVF: Male mice were exposed with i.p. injections of BaP in corn oil or 
injected only with vehicle (corn oil) (chapter 2.3.2). 
2. Day 3 before IVF: Female mice were injected i.p. with 5 international units (IU) of 
the pregnant mare serum hormone gonadotropin (PMSG). 
3. Day 1 before IVF: Female mice were injected i.p. with 5IU of the human chorionic 
gonadotropin (HCG). 
4. Day of IVF: Male and female mice were sacrificed by cervical dislocation. Caudas 
and oviducts were surgically removed (chapter 2.2.2) and collected in Eppendorf 
tubes containing M2 medium that were kept in room temperature.  
5. Micro scissor were used to make incisions in cauda and the sperm dispersed for 10 
min in 250 µl human tubal fluid (HTF) medium under liquid paraffin. Egg clutches 
with 10-20 oocytes in cumulus cells were removed from each oviduct.  
6. Sperm cells and oocytes were transferred to IVF dishes and incubated in 250 µl of 
HTF medium under liquid paraffin for 4.5 hours at 37ºC.  
7. The fertilized oocytes (zygotes) were washed 5 times in 150 µl potassium simplex 
optimisation medium (KSOM) for removal of cumulus and sperm cells and 
transferred to 150 µl KSOM in a petri dish under liquid paraffin. 
8. Embryos from the first cell stage were collected immediately and the rest was grown 
and harvested to later developmental stages.  
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2.6 Immunostaining of BPDE-DNA adducts 
Immunocytochemistry (ICC) is broadly applied in research and has great versatility in 
extensive number of fields. The method use antibodies to detect antigens in tissue 
preparations or isolated cells. High affinity and selectivity of the antibody towards the 
epitope on the antigen is necessary, and a fluorophore attached to the antibody (primary or 
secondary) are needed to generate fluorescence signal (Parham 2009). The main adducts 
after BaP-exposure in vivo are the BPDE-DNA adducts (chapter 1.7.1). An antibody towards 
BPDE-DNA adduct was used in the immunostaining experiments. The primary monoclonal 
antibody BPDE, clone 5D11 from mouse IgG2a was used (Nordic BioSite AS) (Santella et 
al., 1984; Santella et al., 1988). A secondary antibody, donkey anti-mouse labelled with 
fluorophore Alexa 488 (Invitrogen), was used to visualise binding of the primary antibody.  
Murine hepatoma cells (Hepa1c1c7, obtained from the MILS department at NIPH) were 
exposed to a high dose of BPDE in vitro and used as a positive control for the optimisation 
of the staining procedure. Cells were transferred to slides and tested with different 
concentrations of the antibodies. DNA denaturation with Hydrogen chloride (HCl) was a 
part of the immunostaining procedure to denaturise DNA and thus increase the availability 
of the DNA adducts to antibody recognition.  Different concentrations of HCl were tested to 
the specimens to optimise the staining procedure (denaturation conditions and antibody 
concentrations).   
Embryos from BaP exposed fathers were obtained by IVF, but there were some difficulties 
with the preparations during the immunostaining procedure. The challenge was to obtain a 
technique where a few embryos could be stained and visualised without being lost during the 
procedure. Embryos placed directly on slides were easily lost. Fibrinogen clots that captured 
the embryos were therefore assessed, as this procedure is used for normal embryo-
immunostaining studies in the lab. A few embryos were transferred to 20 µl fibrinogen 
(solved in KSOM) and added thrombin to solidify. However, the clot and embryos did not 
tolerate the acid denaturation step in the procedure. Subsequently, a clot with embryos inside 
1 % agarose in PBS with EDTA was tried. This composition tolerated the denaturation step. 
However, staining results were poor when examined by fluorescence microscopy for 
unknown reasons. Solutions and chemicals were prepared and ordered fresh before 
additional experiments. Oocytes were easier to obtain than embryos, and for further testing 
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of the procedure oocytes were exposed to a high dose (10 µM) BPDE in vitro as a positive 
control for staining of BPDE-DNA adducts. Oocytes were removed from mice in the same 
way as for IVF (chapter 2.2.2). The procedures for exposure in vitro and capture in agarose 
clots were similar for oocytes and embryos. The only difference was removal of cumulus 
cells with Hyase before exposure of the oocytes. Somatic testicular cells from an unexposed 
mouse were also exposed to a high dose of BPDE in vitro when staining results were weak 
in embryos and oocytes. This was to examine if there was something in the embryos, oocytes 
or the agarose clot that did not allow staining or if the procedure unexpectedly did not work. 
Somatic testicular cells were expected to have the same response as hepatoma cells to a high 
dose of BPDE in vitro. Unfortunately, some methodological problems occurred that were not 
solved due to the time limits of this master thesis.  
The immunostaining procedure was mutual for all cell types, with different exposure and 
preparation techniques. Hepatoma cells, testicular cells and oocytes were only exposed to 
BPDE in vitro, whereas embryos were exposed both in vitro as a positive control and in vivo 
through BaP-exposure of the father. The procedure for embryos is described with use of the 
agarose clot, and denaturation concentration is 2 N HCl. Preparations, exposure and fixation 
of the individual cells are described first, followed by the general procedure for 
immunostaining. Unexposed control cells were prepared for all experiments and all 
precautions for handling BPDE were followed.  
2.6.1 Preperation of hepatoma and testicular cells and BPDE exposure in 
vitro 
Procedure hepatoma cells: 
1. Murine hepatoma cells (Hepa1c1c7) were grown in four petri dishes in serum-free 
Minimum Essential Medium (MEM) Alpha medium inside a cell incubator to 
maintain optimal conditions. 3 ml fresh medium was transferred to the cells before 
exposure of BPDE. 
2. Two of the petri dishes were exposed to 3.5 µl (1 mM) BPDE to a final concentration 
of 1.2 µM, and the other two dishes were added 3.5 µl DMSO (control). The dishes 
were gently mixed. Sterile pipette tips were used and the exposure was performed in 
a biohazard bench. 
3. Cells were incubated at 37°C in 1 hour. 
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4. The medium was aspirated and cells were washed two times with 3 ml PBS. 1 ml 
Trypsin was transferred to each dish to detach the cells, and cells were incubated at 
37°C in 2 min. 
5. Each dish were added 3 ml fresh MEM Alpha medium and mixed gently. 
6. The medium with cells (1ml) from each dish were transferred to four Eppendorf 
tubes and centrifuged (Eppendorf centrifuge 5415R) at 288 x g in 5 min at room 
temperature. 
7. The supernatants were aspirated and the pellets were re-suspended in 1 ml PBS and 
200 µl fetal calf serum (FCS).       
Procedure testicular cells: 
1. Testes were surgically removed from an unexposed control mouse and placed in an 
Eppendorf tube with PBS.  
2. The internal spermatic fascia (membrane around the testis) and blood vessels were 
removed by a chirurgical scissor and the testis were placed in a small petri dish with 
1.5 ml PBS.  
3. The testis was incised with a surgical scissor approximately 100 times followed by a 
filtration through a 55 µm filter into an Eppendorf tube. This is a rough method to 
separate individual cells from the testis. 
4. Cells were exposed to 5 µl (1 mM) BPDE in Eppendorf tubes to a final concentration 
of 10 µM and control cells were added 5 µl PBS. Sterile pipette tips were used and 
the exposure was performed in a bio hazard bench. 
5. The cells were incubated at 37 °C in 1 hour and centrifuged (Eppendorf centrifuge 
5415R) at 288 x g in 5 min at room temperature. 
6. The supernatants were aspirated and the pellets were resuspended in 200 µl PBS and 
100 µl FCS.  
Fixation procedure for hepatoma and testicular cells: 
1. Hepatoma or testicular cells in PBS (7.5 µl) were transferred to slides and air dried.  
2. The cells were fixed for 3 min in 150 ml cold 70 % methanol in a slide container.  
3. The cells were then transferred to a slide container with 150 ml cold Acetone for 30 
seconds.  
4. The slides were air dried and stored at -20°C.  
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5. An ImmEdge pen (Vector Laboratories Inc) was used to encircle the cells for a more 
restricted area for incubation of the antibodies. 
6. The general immunostaining procedure was then followed for hepatoma cells and 
testicular cells.  
2.6.2 Preperation of embryos and BPDE exposure in vitro 
Procedure for preparation and fixation: 
A stereo microscope (Olympus) was used for visualisation of oocytes and embryos, and 
handling was performed on a heating block at 37ºC. A mouth pipette with a thin glass tip 
was used for transfer of the oocytes and embryos, and they were kept in a cell incubator 
between all steps in the procedure to maintain optimal conditions before fixation.  
1. Female super-ovulated mice were killed by cervical dislocation and oviducts were 
surgically removed and collected in Eppendorf tubes with M2 medium and kept in 
room temperature. 
2. Egg clutches with 10-20 oocytes surrounded by cumulus cells were removed from 
each oviduct.  
3. IVF was performed as described in chapter 2.5. 
4. Gel film placed on 37°C was added 20 µl 1 % low melting point agarose in PBS with 
10 mM EDTA. 3 µl KSOM with 5-10 embryos obtained by IVF were transferred to 
the agarose clot using a 0.5–10 µl pipette with thin tip.  
5. The agarose clots with embryos on gel film were placed on a cold plate to make the 
agarose solidify. 
6. The agarose clots on gel film were placed in a dish and fixated in 50 ml 70 % cold 
methanol for 3 min. The general immunostaining procedure was then immediately 
followed. 
Procedure for BPDE exposure to embryos and oocytes in vitro: 
1. Embryos obtained by IVF were washed 5 times in drops of 150 µl KSOM under 
liquid paraffin. 
2. In a biohazard bench, a drop with 495 µl KSOM and 5 µl (1 mM) BPDE to a final 
concentration of 10 µM was prepared in a petri dish under liquid paraffin. The 
embryos were transferred and incubated at 37 °C in 1 hour.  
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3. The embryos were washed 3 times in drops of 150 µl KSOM and transferred to 
agarose clots and fixed as described above. The general immunostaining procedure 
was then immediately followed. 
2.6.3 General procedure for immunostaining of BPDE-DNA adducts 
The volumes described in the different steps of the immunostaining procedure were added to 
one clot with embryos or oocytes, or one ring made by the ImmEdge pen around hepatoma 
cells and testicular cells.  
1. Cells were washed 2 x 5 in PBS on a tilt board and then rinsed quickly in ddH20. 
2. RNA in cells was removed by adding 20 µl RNase-it (2 mg/ml RNase A and 5000 
U/ml Rnase T1 in 50 mM Tris-HCl (pH 7.4), 50% glycerol). This is to enable 
visualisation of mitochondria and nuclear DNA staining. Cells were incubated at 
37°C for 1 hour and then washed 1 x 5 min in PBS. Slides or gel film with cells were 
air dried.  
3. To digest proteins and reduce background, 20 µl Proteinase K (10 µg/ml Tris buffer) 
was added to the cells for 5 min. Proteinase K also inactivates nucleases that 
otherwise could degrade the nuclear acids in DNA. 
4. Cells were then washed 3 x 5 min in PBD (PBS with 0.1 % Triton X-100) and 
transferred to PBS before a quick rinse in ddH20. 
5. The cells were denaturised in 2N HCl in 10 min to obtain a more open configuration 
of DNA, and then neutralised in Tris base solution in 10 min. Cells were washed 2 x 
2 min in PBS.  
6. To block unspecific binding of the antibody, 20 µl blocking solution (5 % bovine 
serum albumin (BSA) in PBS) was added for 1 hour and the cells were then rinsed 
quickly in PBS. 
7. Cells were incubated overnight at 4°C with 20 µl primary antibody (BPDE 5D11) in 
a 1:200 dilution with 1 % BSA in PBS.  
8. The morning after, cells were washed 3 x 3 min in PBD and added 20 µl secondary 
Alexa 488 labelled antibody in a 1:1000 dilution with 1 % BSA in PBS. Cells were 
kept in the dark for 30 min and then washed 2 x 10 min in PBD.  
9. The cells were carefully transferred to a glass container with 1500 µl hoechst 33342 
in 150 ml PBD. Since hoechst is toxic, this glass container was specifically used for 
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this purpose and a biohazard bench was used. Hoechst is a DNA intercalating agent 
and stains nuclei.  
10. The cells were rinsed quickly in ddH2O, then air dried and a drop of Dako 
cytomation fluorescence medium was added. Cover glasses were placed over the 
cells and excess air bubbles was removed with a pipette tip. The cells on slides or gel 
film were stored at 4°C until examination by fluorescence microscopy.  
A Zeiss Axioplan 2 microscope (5883) equipped with FITC and UV blocks was used for 
visualisation of Alexa 488 and hoechst staining, respectively. A Spot RT3 Slider digital 
camera and Spot advanced software from Diagnostic Instrument Inc., was used for capturing 
images. Immersol® (1-2 drops) was added to the slides for improved resolution in oil 
immersion objectives.  
2.7 Pig-a assay for measuring in vivo somatic mutations 
The Pig-a assay for measuring somatic mutations in vivo is described and established by 
Litron Laboratories (Bryce et al., 2008). The procedure is still in a process of optimisation 
and characterisation and the MIKT-lab is a part of this work. The assay uses blood samples 
collected during the experiment, the volume needed is low and blood withdrawal do not 
affect the animals. The first step in the Pig-a assay was separation of red blood cells from 
other components in the blood stream, achieved by optional gradient centrifugation 
(leukodepletion) (figure 2.2). Different leukodepletion solutions including Nycoprep, 
Lymphoprep and Lympholyte were tested. Separation of the cells with Lympholyte gave a 
distinct pellet of red blood cells that was easier to work with compared to the other 
separation solutions. The isolated red blood cells were then incubated with a phycoerythrin 
(PE) labelled antibody, specific for the cell surface protein CD24 in mice (antiCD24-PE). 
Further incubation with the nucleic acid dye Syto13, made it possible to identify 
reticulocytes (RETs) due to the messenger ribonucleic acid (mRNA) content in RETs. 
Syto13 emits green fluorescence in the Fluorescein isothiocyanate (FITC)-channel. Flow 
cytometry with BD FACSDiva (v 6.1.2) software was used to analyse the blood samples.  
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Fig 2.2 Basic steps of the pig-a assay. Blood are collected from mice before a leukodepletion of red blood cells 
for separation from other components in the blood. The assay continues with antibody labelling (antiCD24-PE) 
and incubation with a nucleic acid dye (Syto13). Samples are then analysed by flow cytometry (Dobrovolsky et 
al., 2010). 
A calibration standard was used before every experiment to calibrate the flow cytometer and 
adjust gates in the cytogram that distinguish mutated and non-mutated RETs and RBCs 
(figure 2.3). The standards were made of blood from untreated control mice and followed the 
Pig-a procedure in parallel with the other samples. The volume withdrawn from these mice 
was doubled compared to the other samples. Half of the native cells were then labelled with 
the antibody to CD24, while the other half remained unlabelled. The cells that were 
unlabelled imitate the phenotype of cells with a mutation in the Pig-a gene, and are referred 
to as “mutant mimics”. The calibration standard was also treated with Syto13. Compensation 
was performed to avoid overlapping of the two fluorescence emissions (PE and Syto13). 
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Figure 2.3 Cytogram obtained by flow cytometry showing a calibration standard for the Pig-a assay. The main 
cell population to the right is treated with the antibody towards CD24 (antiCD24-PE), while the population to 
the left is untreated and referred to as “mutant mimics”.  Syto13-fluorescence on the y-axis distinguishes 
reticulocytes (RETs) and mature red blood cells (RBCs).  PE-fluorescence represents cells with attached 
antibody. The cytogram is divided into four quadrants and represent mutated (CD24 negative, Q1, Q3) and 
non-mutated (CD24 positive, Q2, Q4) RETs and RBCs.  
In the pilot studies performed in the present master, the needed reagents and solutions were 
ordered by the MIKT-lab. When the assay demonstrated to provide sensitive and repeatable 
results, Litrons prototype kit containing all the required solutions were used. Standard kits 
make it possible to achieve a similar basis for all experiments and to compare the results 
with other labs. This is useful since the Pig-a assay is a relatively new and under current 
establishment at several laboratories. Two pilot experiments are described first, followed by 
the full Pig-a procedure. 
2.7.1 Dose-response analysis with “mutant mimics” 
A dose-response experiment with a dilution series of “mutant mimic” unlabelled cells mixed 
with a labelled antiCD24-PE blood sample was conducted in order to examine the 
performance of the assay. Blood was collected from untreated control mice, which are 
expected to have a natural low mutation load. Number of blood cells in a sample with 
isolated red blood cells was estimated by manual cell counting in a hemocytometer under 
light microscope. A dilution series with an estimated number of untreated blood cells were 
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then made. Before flow analysis, the samples from the dilution series were mixed with a 
sample of blood cells treated with antibody. This was to examine if the flow cytometer was 
able to detect the untreated cells as mutants. Solution and chemicals from the MIKT-lab 
were used and the number of cells counted in the flow cytometer for each sample was 10
5 
cells. 
Procedure: 
1. Blood samples were collected from the saphenous vein in untreated control mice as 
described in chapter 2.2.3. 60-100 µl blood from each mouse was transferred directly 
into small heparin-coated tubes. Samples were then transferred to Eppendorf tubes 
with heparin in PBS (1:10) to further avoid coagulation. The pig-a assay (chapter 
2.7.3) was applied for all samples including a calibration standard. Half of one of the 
samples was kept untreated with antiCD24-PE.  
2. The untreated blood sample was used to make the dilution series of “mutant mimic” 
cells. First, 10 µl cells from this sample was mixed with 10 µl Tryphan blue and then 
diluted in PBS (1:200 total dilution) for cell counting. This was performed 3 times to 
achieve a mean value of cells in the sample.  
3. Mean number of cells in these three samples was 1.27 x 109 cells/ml blood. 
4. 100 µl unlabeled cells (1.27 x 108 cells) was incubated with 900 µl Syto13 solution. 
This was the first sample in the dilution series.  
5.  The dilution series was made by transferring 100 µl to new tubes with 900 µl Syto13 
(1:10).  
6. The dilution series consisted of 4 Eppendorf tubes with approximately 1.27 x 108, 
1.27 x 10
7
, 1.27 x 10
6
 and 1.27 x 10
5
 cells/ml in Syto13. 
7. According to the cell count, 200 µl of the blood sample that was labelled with 
antiCD24-PE contained an approximate number of 2, 54 x 10
8
 cells. 
8. 50 µl unlabelled cells from each of the four tubes was mixed with 200 µl labelled 
cells. The proportion of unlabelled to labelled cells was therefore approximately 1:40 
(2.54 x 10
8
/6.35 x 10
6
), 1:400, 1:4000 and 1:40 000 in sample 1-4, respectively. 
9. Since 105 cells were run through the cytometer, the blood samples contained an 
estimated number of 2500, 250, 25 and 2.5 unlabelled cells pr 10
5
 labelled cells. 
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2.7.2 Visualisation of platelets and lymphocytes in the flow cytogram 
In the Pig-a assay, it is important to avoid platelets and lymphocytes in the analysis of 
mutated cells. Platelets and lymphocytes were isolated from red blood cells in order to 
examine where these cells were localised in the flow cytograms that are used during Pig-a 
analyses. An allophycocyanin (APC) labelled antibody towards platelets (CD42d-APC) was 
used for visualisation of platelets, and Syto13 for visualisation of lymphocytes since these 
have a high staining as they are nucleated cells. Isolated platelets and lymphocytes were 
mixed with a sample of native isolated red blood cells that had followed the Pig-assay. This 
was to compare where the cell types were localised in the same cytogram. The sizes of the 
three cell types are different so it should be possible to separate the individual cell 
populations in forward and side scatter flow diagrams. Flow cytometry can also gate out 
different cell populations for a more accurate examination of number and localisation of 
cells. Knowledge of where platelets and lymphocytes are localised in the Pig-a cytograms 
would be useful to avoid contamination of these in red blood samples, which makes the 
assay more reliable. Two different concentrations of CD42d-APC were tested and we 
concluded that a 1:10 dilution gave the best visualisation. Solution and chemicals from the 
MIKT-lab were used.  
Procedure: 
1. Blood samples were collected by heart puncture in 4 untreated control mice using a 
heparin coated needle (chapter 2.1.2). Blood were immediately transferred to heparin 
coated tubes (BD Vacutainer 13 x 10 mm).  
2. A volume of 1 ml blood was mixed with 1 ml PBS and gently layered on top of 1 ml 
Lympholyte. The sample was centrifuged (Eppendorf centrifuge 5810R) at 800 x g 
for 20 min in room temperature.  
3. The lymphocytes and platelets were gathered in a thin grey layer on top of the 
Lympholyte, this layer was transferred by a pipette to an Eppendorf tube. 10 µl was 
transferred to a slide and examined in a light microscope to make sure that these cells 
were present in the sample.  
4. The grey layer with cells were mixed with 1 ml PBS and centrifuged (Eppendorf 
centrifuge 5810R) at 300 x g for 10 min in room temperature. The supernatant was 
aspirated and the pellet was resuspended in 600 µl PBS. From now on the sample 
were kept on ice and protected from light until flow analyses. 
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5. A 1:10 dilution of CD42d-APC (2 % FCS in PBS) was prepared and 100 µl platelets 
and lymphocytes were transferred to 100 µl of this antibody solution and incubated in 
30 min on ice in the dark.  
6. The sample was mixed carefully and transferred to a new Falcon tube (15 ml) on top 
of 10 ml PBS before centrifugation (Eppendorf centrifuge 5810R) at 300 x g for 5 
min in room temperature.  
7. The supernatant was aspirated and 1.5 ml Syto13 (0.12 µM syto13 in FCS) was 
transferred to the tube before incubation at 37 °C in 30 min. The samples were kept 
on ice until flow analysis. 
2.7.3 Pig-a analysis of of N-ethyl-N-nitrosourea (ENU) exposed mice in vivo 
When a stable gating strategy of the calibration standard and the procedure for isolation of 
red blood cells was outlined, a long term experiment with exposure of mice to the potent 
mutagen N-ethyl-N-nitrosourea (ENU) was conducted in order to examine the performance 
of the Pig-a assay. Mice were divided into three treatment groups. These were untreated, 
vehicle (solvent) and ENU exposed and the mice were followed over a period of 5 weeks. 
The Pig-a procedure was performed on blood samples from mice pre-exposure, 2 weeks and 
5 weeks after exposure. The experiments used chemicals and solutions obtained from Litrons 
prototype kit.  
Procedure: 
1. Blood samples were collected from the saphenous vein in mice as described in 
chapter 2.2.3, and transferred directly into small heparin-coated tubes. Volumes 
ranging from 60-100 µl were collected from each mouse.  
2. Blood in volumes of 30 µl were immediately transferred to pre-labelled Eppendorf 
tubes with 100 µl Anti Coagulant Solution on ice. 60 µl blood from an untreated 
mouse was transferred to one of the Eppendorf tubes as a calibration standard.  
3. Falcon tubes (15 ml) containing 3 ml Lympholyte® had been equilibrated to room 
temperature in advance, and 130 µl (160 µl for calibration standard) of blood in 
Anticoagulant Solution was gently layered on top of the Lympholyte®. The samples 
were centrifuged (Eppendorf centrifuge 5810R) at 800 x g in 20 min at room 
temperature. 
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4. The supernatants were aspirated carefully without disturbing the pellets, and the 
surfaces of the pellets were washed two times in 300 µl Buffered Salt Solution 
(BSS). 
5. BSS was transferred in volumes of 155 µl (310 µl for calibration standard) to the 
pellets and mixed gently. From now on the samples were kept on ice and protected 
from light until flow analyses.  
6. Blood samples were transferred to Eppendorf tubes containing 100 µl cold Working 
Antibody Solution (1:20 stock antiCD24-PE in 2 % FBS in BSS) in volumes of 150 
µl. The calibration standard was split into two Eppendorf tubes. 150 µl was 
transferred to a tube with 100 µl Working Antibody Solution and 160 µl was 
transferred to a tube with 2 % FCS in BSS. All samples were incubated on ice for 30 
min.  
7. Blood samples were then resuspended by using a pipette, and the whole content in 
each tube was transferred to new Falcon tubes (size 15 ml) containing 10 ml BSS. 
Drops with blood that had missed contact with the Working Antibody Solution were 
not transferred. This is to avoid untreated cells that appear as mutant cells in the flow 
diagram. The samples were centrifuged at 300 x g in 5 min in room temperature. 
8. The supernatants were carefully aspirated and the pellets were added 1.5 ml Working 
Nucleic Acid Dye Solution (0.12 µM syto13 in BSS).  
9. All samples were transferred to new light protected Eppendorf tubes (1.5 ml) and 
incubated at 37°C in 30 min. All tubes were kept on ice until flow cytometric 
analysis.  
2.8 Statistical analyses 
Statistical analyses were conducted on data from the SCSA and Pig-a experiment, to 
examine if there were any statistical significant differences between the different treatment 
groups. For the SCSA, a power analysis was performed in advance of the experiment. This 
was to calculate the number of animals required to be able to detect a biological relevant 
increase in potential BaP-induced DNA damage. Statistical analyses were performed using 
Sigma Plot 11.0 software. The p-value and significance level was set at 0.05 and values 
below this were accepted as statistical significant.  
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The data in the SCSA and Pig-a experiments were initially tested for a normal distribution. 
This was conducted by a Shapiro-Wilk normality test, which tests the null hypothesis that a 
sample comes from a normal distribution. For the SCSA parameters, Q-Q (quantile-quantile) 
probability plots were also used to examine the ordered distribution of data (Henderson 
2006). The Levene’s test for homogeneity of data was also used for initial statistical 
analyses. Normality and an approximately equal variance are requirements for an analysis of 
variance (ANOVA), together with independent observations. The ANOVA tests the null 
hypothesis that there are no differences between group means (Festing and Altman 2002). A 
one-way ANOVA was conducted for the mean Alpha t and % High green parameter in the 
SCSA, and for the analysis of mutated RBCs in the Pig-a experiment. A one-way ANOVA 
can be used for comparing multiple groups with one factor variable, and because it is a 
robust test, small deviations from the mentioned requirements can be tolerated (Lovell and 
Omori 2008). An equal variance is more essential than full normality of the data.  
When the parametric test (ANOVA) requirements were not met, the non parametric Kruskal-
Wallis test was used. Kruskal-Wallis is the non-parametric version of the one-way ANOVA 
(Festing and Altman 2002). A Kruskal-Wallis test was used to test whether there were any 
statistical significant differences in medians for the treatment groups in the % DFI parameter 
in the SCSA. The Kruskal-Wallis test does not assume a normal distribution, although an 
identical shaped and scaled distribution for each group (except differences in medians) is 
assumed.  
When the results from a one-way ANOVA or Kruskal-Wallis test indicated a statistical 
significant difference between groups, an additional post-hoc test was used. A lot of such 
tests are available, and they examine between which groups there were differences. The 
Fisher least significant difference (LSD) test for multiple pair wise comparison of groups 
(Meier 2006) was conducted as a post-hoc test in this statistical analyses. This was due to a 
relatively few groups compared, and the SCSA data also had unequal number of animals in 
each group (n). The non-parametric Mann-Withney test was conducted on data from the Pig-
a experiment to examine whether two independent samples were statistical significant 
different from each other.  
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3. Results 
3.1 Analysis of DNA damage in sperm cells by the SCSA 
Paternal BaP-exposure 1-2 weeks before fertilisation is associated with embryo lethality in 
mice (Generoso et al., 1982). The SCSA is an assay for evaluation of sperm chromatin 
integrity in both human and animal samples, and was used in this project in order to examine 
if the assay was able to detect BaP-induced sperm DNA damage in mice.   
3.1.1 Dose-response analalsysis of DNase exposed sperm cells by the SCSA 
A dose-response analysis with exposure of sperm cells to an increasing concentration of 
DNase enzyme (0, 0.2, 2, 20, 200 U/ml)) was conducted in order to examine the sensitivity 
of the SCSA, and the performance of the mean Alpha t and % DFI parameters. Figure 3.1 
shows a clear dose-dependent increase in DNA damage of sperm cells following DNase 
exposure. The Alpha t parameter (red/total fluorescence) seems to be fairly linear following 
increasing levels of DNase. The percentage of damaged cells expressed as % DFI is nearly 
saturated after the lowest DNase concentration (0.2 U/ml). 
 
Figure 3.1 Dose-response analysis of DNase exposed sperm cells by the SCSA, showing data for the 
parameters mean Alpha t and % DFI (DNA fragmentation index).   
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Figure 3.2 shows cytograms obtained by flow cytometry of sperm cells in the dose-response 
analysis with DNase exposure. The main population of cells shifts towards higher red 
fluorescence in the diagrams following higher concentrations of DNase, indicating an 
increased level of single stranded DNA in cells.  
Figure 3.2 SCSA cytograms of caudal sperm cells treated with DNase enzyme. 10 000 sperm cells were 
stained by acridine orange (AO) and are analysed by flow the cytometer for each sample. Green fluorescence 
on the y-axis represents dsDNA and red fluorescence on the x-axis represents ssDNA. A gate is placed around 
the population of sperm cells to eliminate debris. (a) Sperm cells without DNase treatment (control sample) (b) 
Sperm cells treated with 0.2 U/ml DNase (c) Sperm cells treated with 2 U/ml DNase (d) Sperm cells treated 
with 20 U/ml DNase (e) Sperm cells treated with 200 U /ml DNase.  
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3.1.2 SCSA analysis of sperm cells from in vivo BaP-exposed mice 
The chromatin integrity in sperm cells from mice was examined by the SCSA, ten days after 
administration of BaP, corn oil (vehicle control) or no exposure (control). The experiment 
initially included both Ogg1
+/+ 
and Ogg1
-/- 
mice in the three treatment groups for comparison 
of responses in normal and repair deficient mice. However, after correcting for a mistake 
with genotyping of animals, several of the Ogg1
-/-
 animals proved to have the genotype 
Ogg1
+/+
 or Ogg1
+/-
. Ogg1
+/+
 and Ogg1
+/-
 animals express the OGG1 gene for repair of 8-
oxoG and have shown to have a normal repair capacity compared to the decreased repair 
capacity in Ogg1
-/-
 animals (Personal communication, Ann Karin Olsen). Ogg1
+/+
 and 
Ogg1
+/-
 animals were therefore expected to have a similar response to the different 
treatments, and data from these two groups were merged together for unexposed (control) 
and BaP treated animals. These to genotypes together are from now on referred to as Ogg1
wt
. 
Table 3.1 shows the composition of genotypes and treatments that were initially planned for 
the experiment, together with the actual genotypes of animals in the three treatments groups. 
The unexposed control and vehicle groups contained only two and one Ogg1
-/-
 animals, 
respectively. Comparison of Ogg1
+/+
 and Ogg1
-/-
 animals in these treatment groups was 
therefore impossible, and there were not enough animals for a valid statistical analysis. The 
table also shows the genotypes of mice in the three treatment groups that were used for 
analysing the SCSA result. 
Table 3.1 Genotypes of mice analysed by the SCSA. Nr. 1 shows genotypes in the treatment groups that were 
planned for the experiment, and nr. 2 show genotypes that actually were present in the three treatment groups 
after correcting for a mistake with genotyping of animals. Nr. 3 shows the genotypes in treatment groups that 
were used in the SCSA analyses after merging the Ogg1
+/+
 and Ogg1
+/-
 mice to Ogg1
wt
. *Three used as a 
reference sample.  
1: Planned genotypes of mice (no, mice)  Genotype Ogg1
+/+
 Genotype Ogg1
-/-
  Genotype Ogg1
+/-
 
(16) Control 9 7 0 
(16) Vehicle 9 7 0 
(19) BaP-exposed 9 10 0 
2: Actual genotypes of mice (no, mice) Genotype Ogg1
+/+
 Genotype Ogg1
-/-
  Genotype Ogg1
+/-
 
(16) Control 9 (6*) 2 5 
(16) Vehicle 15 1 0 
(19) BaP-exposed 9 7 3 
3: Genotypes of mice used (no, mice) Genotype Ogg1
wt
 Genotype Ogg1
-/-
  
(14) Control 14 0  
(15) Vehicle 15 0  
(19) BaP-exposed 12 7  
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Figure 3.3 shows results for all genotypes, including the Ogg1
+/-
 mice compared with all 
other groups in the three SCSA parameters before fusion with the Ogg1
+/+
 mice. The figure 
shows some differences between the Ogg1
+/-
 and Ogg1
+/+
 animals. However, the observed 
differences were considered random variation due to small sample size. The conclusion was 
that a mutual repair capacity was a valid argument for merging of the two genotypes before 
the SCSA analysis.  
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Figure 3.3 SCSA results in the mean Alpha t, % High green and % DFI parameters before merging the Ogg1
+/+
 
and Ogg1
+/-
 animals to Ogg1
wt
. The genotypes and treatments are Ctrl-Ogg1
+/+
 (n=6), Oil-Ogg1
+/+
 (n=15), BaP-
Ogg1
+/+
 (n=9), BaP-Ogg1
-/- 
(n=7), Ctrl-Ogg1
+/-
 (n=5) and BaP-Ogg1
+/-
 (n=3). The error bars are the standard 
error of the mean (SE) for all individual groups.  
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Sperm cells from three of the control animals (Ctrl-Ogg1
+/+
) were pooled and used as a 
reference sample and are therefore not included in the SCSA results. Table 3.2 shows the 
result in mean Alpha t, % High green and % DFI for Ogg1
wt
 and Ogg1
-/-
 animals. The mean 
values for all three parameters (mean Alpha t, % High green and % DFI) in BaP exposed 
Ogg1
wt
 mice were slightly higher than in the other groups. The BaP exposed Ogg1
-/-
 mice 
had lower mean values than the other groups. The BaP exposed Ogg1
wt
 group had one 
sample with a high level of damage. The SD for this group was therefore also increased, 
especially in the % DFI parameter. The vehicle exposed Ogg1
wt
 groups also showed an 
increased SD for the % DFI parameter.  
Table 3.2 Results for mean Alpha t, % High green and % DFI parameters from the SCSA. Control, oil and 
BaP-exposed animals are shown. Ogg1
wt
 mice are represented in all treatments, while Ogg1
-/- 
mice are only 
available in the BaP exposed group. Mean, standard deviation (SD) and minimum and maximum values were 
calculated, and are shown for all groups and parameters.  
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Parameter Mean Alpha t    
Treatment Ctrl-Ogg1
wt
 Oil-Ogg1
wt
 BaP-Ogg1
wt
 BaP-Ogg1
-/-
 
 19.88 20.83 18.48 16.81 
 19.15 18.98 19.63 18.08 
 19.44 19.62 19.5 18.21 
 20.14 17.59 24.21 19.7 
 19.99 17.71 18.94 19.71 
 18.89 19.21 17.54 19.66 
 17.52 20.11 19.46 18.08 
 19.02 19.3 18.77  
 18.52 19.15 18.63  
 18.34 19.36 19.28  
 19.01 19.23 19.45  
  18.45 19.61  
  18.58   
  19.78   
  18.68   
Mean and SD 19.08 (SD 0.78) 19.11 (SD 0.84) 19.46 (SD 1.62) 18.61 (SD 1.12) 
(min - max) (17.52 - 20.14) (17.59 - 20.83) (17.54 - 24.21) (16.81 - 19.71) 
     
Parameter % High green    
Treatment Ctrl-Ogg1
wt
 Oil-Ogg1
wt
 BaP-Ogg1
wt
 BaP-Ogg1
-/-
 
 4.28 2.96 2.19 1.64 
 3.26 2.25 3.83 1.89 
 4.84 3.38 1.26 2.09 
 3.25 3.32 6.64 2.28 
 3.34 7.49 4.96 1.92 
 9 4.89 8.02 1.35 
 5.06 3.82 4.28 2.18 
 5.56 3.1 5.26  
 5.28 2.55 5.26  
 4.44 3.15 8.01  
 4.55 6.33 3.98  
  4.65 6.24  
  5.17   
  4.59   
  6.48   
Mean and SD 4.81 (SD 1.61) 4.28 (SD 1.56) 4.99 (SD 2.07) 1.91 (SD 0.32) 
(min - max) (3.25 - 9) (2.25 - 7.49) (1.26 - 8.02) (1.35 - 2.28) 
     
Parameter % DFI    
Treatment Ctrl-Ogg1
wt
 Oil-Ogg1
wt
 BaP-Ogg1
wt
 BaP-Ogg1
-/-
 
 7.87 32.59 3.59 1.5 
 2.88 3 5.86 0.96 
 5.01 6.99 4.3 1.65 
 16.67 4.3 70.57 9.94 
 6.91 3.55 2.87 8.01 
 5.31 4.01 3.59 5.87 
 3.46 14.94 6.14 2.92 
 6.04 4.51 4.2  
 4.4 4.43 4.07  
 5.85 4.5 7.32  
 6.11 4.96 4.32  
  4.55 7.29  
  2.46   
  10.53   
  3.11   
Mean and SD 6.41 (SD 3.70) 7.23 (SD 7.74) 10.34 (SD 19.02) 4.41 (SD 3.56) 
(min - max) ( 2.88 - 16.67) ( 2.46 - 32.59) ( 2.87 - 70.57) ( 0.96 - 9.94) 
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3.1.3 The Alpha t parameter was not influenced by BaP-exposure  
Figure 3.4 shows mean and median Alpha t for control, vehicle and BaP exposed mice in the 
SCSA experiment. 
 
Figure 3.4 Box plot showing the result from the Alpha t parameter following analysis of sperm by the SCSA. 
Genotypes and treatment groups are Ctrl-Ogg1
wt
 (n=11), Oil-Ogg1
wt
 (n=15), BaP-Ogg1
wt
 (n=12) and BaP-
Ogg1
-/-
 (n=7). The solid lines are the median for each treatment group and the dashed lines are the mean values. 
The dots outside the boxes are outliers. There are few data points for the Ogg1
-/-
 group, and the 10 % and 90 % 
percentiles were not calculated by the software (Sigma plot 11.0). Minimum and maximum values are shown in 
table 3.2. 
The data for the mean Alpha t parameter was normally distributed in all groups except in the 
BaP-Ogg1
wt 
(p<0.001) group, and the data showed no signs of a non-constant variance 
(p=0.779). A one-way ANOVA was conducted and showed no statistical differences 
between the treatment groups (p=0.477).  
Results 
 55 
3.1.4 The % DFI parameter was not influenced by BaP-exposure 
Figure 3.5 shows mean and median % DFI for the control, vehicle and BaP exposed mice in 
the SCSA experiment. 
 
Figure 3.5 Box plot showing result from the % DFI parameter following analysis of sperm by the SCSA. 
Genotypes and treatment groups are Ctrl-Ogg1
wt
 (n=11), Oil-Ogg1
wt
 (n=15), BaP-Ogg1
wt
 (n=12) and BaP-
Ogg1
-/-
 (n=7). The solid lines are the median for each treatment group and the dashed lines are the mean values. 
The dots outside the boxes are outliers. There are few data points for the BaP-Ogg1
+/-
 group, and the 10 % and 
90 % percentiles were not calculated by the software (Sigma plot 11.0). Minimum and maximum values are 
shown in table 3.2. 
Figure 3.5 show that the BaP-Ogg1
wt
 group had a slightly higher mean value than the other 
groups. The BaP-Ogg1
wt
 data also had a high dispersal of data. This may partly be due to the 
outlier shown in table 3.2. Data for the % DFI parameter was not normally distributed 
(p<0.001), although the data showed no signs of a non-constant variance (p=0.826). The 
non-parametric Kruskal-Wallis test for comparison of all groups against each other was 
conducted. There were no statistical significant differences between any of the treatment 
groups in the % DFI parameter in the SCSA (p=0.532).  
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3.1.5 BaP-exposed Ogg1-/- mice have a reduced number of immature cauda 
sperm  
Figure 3.6 shows mean and median % High green for control, vehicle and BaP exposed mice 
in the SCSA experiment. 
 
Figure 3.6 Box plot showing result from the % High green parameter following analysis of sperm by the 
SCSA. Genotypes and treatment groups are Ctrl-Ogg1
wt
 (n=11), Oil-Ogg1
wt
 (n=15), BaP-Ogg1
wt
 (n=12) and 
BaP-Ogg1
-/-
 (n=7). The solid lines are the median for each treatment group and the dashed lines are the mean 
values. The dots outside the boxes are outliers. There are few data points for the BaP-Ogg1
+/-
 group, and the 10 
% and 90 % percentiles were not calculated by the software (Sigma plot 11.0). Minimum and maximum values 
are shown in table 3.2. (*p<0.003 compared to all Ogg1
wt 
).  
Figure 3.6 shows a decreased median value in the BaP-Ogg1
-/-
 group compared to the others. 
The data for the % High green parameter was normally distributed in all groups except the 
Ctrl-Ogg1
wt 
group (p=0.001). The data showed an equal variance (p=0.119), and a one-way 
ANOVA was conducted and showed statistical significant differences between treatment 
groups (p=0.002). Diagnostic plots showed some indications of a non constant variance, with 
an increasing variance with higher values. A non-parametric Kruskal-Wallis test was 
therefore also conducted, and confirmed that there were statistical significant differences 
between treatment groups (p=0.001). Fisher-LSD post-hoc test for all pair wise multiple 
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comparison was further conducted on data and showed statistical significant differences 
between the BaP-Ogg1
-/-
 and all the Ogg1
wt
 groups (Ctrl-Ogg1
wt
 and BaP-Ogg1
-/-
 (p<0.001), 
Oil-Ogg1
wt
 and BaP-Ogg1
-/-
(p=0.003), BaP-Ogg1
wt
 and BaP-Ogg1
-/-
 (p<0.001). There were 
no statistical significant differences between the treatment groups in the Ogg1
wt
 animals. 
3.2 Immunostaining of BPDE-DNA adducts in BaP exposed cells 
To be able to measure the potential persistence of paternally transmitted BPDE-DNA 
adducts in embryos, a method for immuno-detection of BPDE-DNA adducts was established 
in our lab and modified for the purpose of labelling these adducts in mice embryo. Different 
concentrations of HCl (1N, 2N, 4N) for DNA denaturation and different antibody 
concentrations were tested.  
Immunostaining of hepatoma cells exposed to a high dose of BPDE in vitro gave clear and 
detectable BPDE-DNA adducts visualised by fluorescence microscopy. Figure 3.7 shows 
unexposed and BPDE exposed hepatoma cells treated with 4 N HCl. Staining of the nuclei in 
exposed cells was observed when using 4N HCl, as shown when comparing  image (b) and 
(c). Figure (a) shows that unexposed cells gave fluorescence signal, which further indicates a 
high background of unspecific binding from the antibody following denaturation with 4N 
HCl. 
 
Figure 3.7 Fluorescence images of BPDE exposed hepatoma cells. All cells are denaturised with 4N HCl and 
treated with a 1:200 dilution of primary antibody (anti-BPDE 5D11) and a 1:1000 dilution of secondary Alexa 
488 labelled antibody. Green fluorescence indicates BPDE-DNA adducts. (a) BPDE-staining in unexposed 
control cells (b) BPDE-staining in cells exposed to BPDE (c) Cells nuclei of exposed cells visualised by 
hoechst staining.  
Denaturation with 2N HCl gave visualisation of BPDE-DNA adducts in hepatoma cells after 
BPDE exposure (figure 3.8 (c)). Based on experiments with 2N HCl that gave repeatable 
results and low background level of unspecific binding, we concluded that denaturation with 
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2N HCl gave the best visualisation of BPDE-DNA adducts. Figure 3.8 shows unexposed and 
BPDE exposed hepatoma cells treated with 2N HCl. Figure 3.8 (a) shows cells that are 
exposed to BPDE and labelled with secondary antibody, while untreated with primary 
antibody. This was to observe if the secondary antibody gave unspecific staining. Figure 3.8 
(a) shows that the secondary antibody gives low unspecific background. Figure 3.8 (b) 
further show lack of staining of unexposed cells, while staining was clear in nuclei of BPDE-
exposed cells (c).  
 
Figure 3.8 Fluorescence images of hepatoma cells. All cells are treated with 2N HCl for denaturation. A 1:200 
dilution of primary antibody (anti-BPDE 5D11) and a 1:1000 dilution of secondary Alexa 488 labelled 
antibody are used. (a) Cells treated with BPDE and secondary antibody, while untreated with primary antibody 
(b) BPDE-staining in unexposed control cells (c) BPDE-staining in cells exposed to BPDE  
To be able to stain pre-implantation embryos, the embryos needed to be captured in a matrix. 
The use of fibrinogen clots for capturing embryos is useful for normal immuno 
cytochemistry. However, denaturation with HCl dissolved the fibrinogen clots. As an 
alternative procedure, the embryos were embedded in clots of agarose, which tolerated the 
subsequent treatments. Immunostaining of BPDE-DNA adducts were carried out in embryos 
exposed to BPDE in vitro and BaP through the father in vivo. Staining of BPDE-DNA 
adducts in embryos inside an agarose clot gave poor results for unknown reasons. Due to the 
time limits of this master, results for paternal transfer of BPDE-DNA adducts to embryo 
DNA and 2 and 4 cell stages of embryos are therefore absent. 
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3.3 The Pig-a assay for measuring somatic mutations (in vivo) 
The Pig-a assay for detection of in vivo somatic mutations was established at the MIKT lab 
with the purpose of later studying environmental mutagens, including BaP, with potential 
toxic effects on male germ cells. Experiments were performed using red blood cells isolated 
from small blood samples in mice. A fluorescent RNA/DNA probe (Syto13) and a 
phycoerythrin (PE) labelled antibody to the CD24 marker was used to separate mutated 
(CD24 negative) and non-mutated (CD24 positive) reticulocytes (RETs, Syto13 positive) 
and mature red blood cells (RBCs, Syto13 negative). In this assay, an increased mutation 
frequency is measured as an increase in CD24 negative cells.  
3.3.1 Dose-respons analysis of unlabelled “mutant mimics” 
In order to examine the performance of the Pig-a assay, isolated red blood cells were 
incubated with the CD24 antibody and mixed with a dilution series of unlabelled red blood 
cells. The latter cells are referred to as “mutant mimics”. The number of “mutant mimic” 
cells pr. 10
5
 was estimated by manual cell counting (chapter 2.7.1). Figure 3.9 shows 
cytograms obtained by flow cytometry for the sample containing red blood cells to which 
different number of “mutant mimic” cells were added. The cells with a mutant phenotype 
was localised in the Q1 (RETs) or Q3 (RBCs) quadrants of the cytograms, and figure 3.9 
shows a clear increase in amount of mutated RBCs, with increasing number of mutant 
mimics added.  
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Figure 3.9 Cytograms showing a dose-response experiment with “mutant mimics”. One sample containing red 
blood cells incubated with anti-CD24-PE were allocated and added non-labelled red blood cells from a dilution 
series. (a) Red blood cells labelled with anti-CD24-PE and Syto13 (negative control cells) (b) 10
5
 labelled red 
blood cells added an estimated amount of 2.5 “mutant” cells (c) 10
5 
labelled red blood cells added an estimated 
amount of 25 “mutant” cells (d) 10
5
 labelled red blood cells added an estimated amount of 250 “mutant” cells 
(e) 10
5
 labelled red blood cells added an estimated amount of 2500 “mutant” cells. 
Table 3.3 shows the number of cells from the dose-response experiment with “mutant 
mimics” that were localised in the four quadrants (Q1, Q2, Q3, and Q4) from the cytograms 
in figure 3.9. The pig-a assay was able to separate cells with a mutated phenotype from the 
rest of the cell population. The flow cytometer detected a ten fold increase in the amount of 
“mutant mimic” RBC (Q3), which corresponded well to the ten folds increased 
concentration of added “mutant cells”. The mutated RETs (Q1) showed a background level 
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of false positive (mutated) cells in the control sample (a). The levels of mutated RETs did 
also not increase with increased concentration of “mutant mimic” RETs. This indicates that 
the assay was not detecting the mutated RETs (Q1) as well as the mutated RBC (Q3).  
Table 3.3 Results from the dose-response experiment with “mutant mimics”, showing the number of cells 
detected in each of the four quadrants of the cytograms (figure 3.9). The two columns to the left shows the 
estimated number of un-labelled cells that were added to 10
5
 labelled cells, together with the number of cells 
that the Pig-a assay and flow cytometer detected as mutants. The amount of cells in Q1 and Q3 quadrants 
(mutated RETs and RBCs) are increasing with higher amount of “mutant mimic” cells added. Quadrant Q2 and 
Q4 shows labelled cells in the blood population. Data are obtained by flow cytometry and BD FACSDiva 
software (v 6.1.2). 
 
3.3.2 Visualisation of platelets and lymphocytes in flow diagrams 
Platelets and lymphocytes were visualised in forward and side scatter cytograms to examine 
the localisation of these compared to the red blood cells. This was to decrease the possibility 
of contamination of these cell types in samples with red blood cells during flow analysis. 
Figure 3.10 shows cytograms obtained by flow cytometry for samples containing platelets 
and lymphocytes. An allophycocyanin (APC) labelled antibody for platelets (CD42d-APC) 
was used to identify the localisation of platelets in the cytogram and staining with Syto13 of 
all cells made it possible to distinguish lymphocytes from red blood cells.  
Sample Q1 
(mutated 
RETs) 
Q2 
(non-
mutated 
RETs) 
Q3 
(mutated 
RBCs) 
Q4 
(non-
mutated 
RBCs) 
Estimated number of 
“mutant mimic” cells 
added to each sample 
(pr. 10
5
 cells) 
Number of “mutant 
mimic” cells detected by 
the flow cytometer      
(pr. 10
5
 cells) 
(a) 7 2237 0 94039 0 7 
(b) 7 2098 2 94002 2.5 9 
(c) 5 2067 12 94137 25 17 
(d) 10 2123 127 94084 250 137 
(e) 15 2092 1095 92912 2500 1110 
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Figure 3.10 Forward and side scatter plots obtained by flow cytometry showing blood samples pooled from 
four unexposed control mice. Lymphocytes are shown in red, platelets in green and red blood cells in blue. 
These cell populations were identified in separate histograms (not shown) due to APC-positively (platelets) and 
Syto13 staining (high in lymphocytes). (a) Lymphocytes and platelets isolated from red blood cells. Cells were 
labelled with antibody for platelets (CD42d-APC) and Syto13 (b) Same sample as (a), only platelets are shown 
(c) Red blood cells isolated from whole blood and labelled with antibody for platelets (CD42d-APC) and Syto13 
(d) Same sample as (c), only platelets are shown. 
Figure 3.10 (a) and (b) shows that the main population of platelets was localised below the 
red blood cells. The lymphocytes were localised mainly above the red blood cells as shown 
in figure 3.10 (a). This information allowed us to more precisely set the gate used in 
subsequent experiments to avoid contamination of platelets and lymphocytes. Figure 3.10 (c 
and d) shows that platelets and lymphocytes were present in a minor amount in the sample of 
isolated red blood cells that had followed the normal pig-a procedure.  
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3.4 The performance of the Pig-a assay in response to (ENU) 
mutagenesis  
The number of mutated RETs and mature RBCs in blood samples from mice was analysed 
by the Pig-a assay after exposure to the model mutagen N-ethyl-N-nitrosourea (ENU). This 
experiment was performed as a positive control to benchmark the performance of the Pig-a 
assay in our lab compared to performance in Litron associated labs. Mice were divided into 
three treatment groups. These were unexposed control (n=2), vehicle (solvent) (n=4) and 
ENU exposed (n=6). The results from analyses pre-exposure (before treatments), two weeks 
and five weeks after exposure are presented in this master thesis. Mutated RETs are shown 
in quadrant Q1 of the cytograms and mutated RBCs are shown in quadrant Q3. Figure 3.11 
shows blood samples from one of the animals in the ENU exposed group following Pig-a 
analysis, pre-exposure, week 2 and week 5 after exposure.  
 
Figure 3.11 Cytograms obtained by flow cytometry showing blood samples from a mouse following the Pig-a 
assay. Syto13-fluorescence on the y-axis indicates RNA content, while PE-fluorescence on the x-axis indicates 
CD24 staining. (a) Pre-exposure Pig-a analysis of one mice from the ENU group (b) Same mouse two weeks 
after ENU-exposure (c) Same mouse five weeks after ENU-exposure.  
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Table 3.4 shows the mean values of cells in the cytograms (Q1, Q2, Q3 and Q4) from the 
whole experiment with ENU exposed mice, including control and solvent treated animals. 
The data was obtained by Pig-a analysis and flow cytometry on blood samples collected pre-
exposure, two weeks and five weeks after exposure. Data showed that the amount of mutated 
RETs (Q1) was generally variable, and high for all treatment groups pre-exposure. This 
indicates a high background of false positive (mutated) RETs. The amount of mutated RBCs 
(Q3) was more stable and showed low background of mutated cells in all treatment groups 
pre-exposure. Mutated RBCs in ENU-exposed animals were increasing following time after 
exposure, which indicates that the assay is relatively sensitive for detecting mutated RBCs. 
Table 3.4 Mean number of cells in each quadrant of cytograms from unexposed (n=2), solvent (n=4) and ENU 
(n=6) exposed animals. Pig-a analysis was performed for every blood sample pre-exposure, week 2 and week 5 
after treatments. Q1 and Q3 represent mean values of mutated RETs and RBCs, respectively, and the standard 
deviations are calculated for these values. Quadrant Q2 and Q4 are non-mutated cells in the blood populations. 
Total amount of cells counted for each sample was approximately 10
5 
cells. Data was obtained by BD 
FACSDiva software (v 6.1.2).   
  Treatment Q1 (mutated RETs) Q2 Q3 (mutated RBCs) Q4 
Pre-exposure Unexposed 57.5 (SD17.7) 37054 1.5 (SD 2.1) 931473 
  Solvent 74 (SD 21.0) 38759 1.5 (SD 0.6) 940834 
  ENU 43.8 (SD 30.5) 36050 3.5 (SD 2.6) 934023 
Week 2 Unexposed 9 (SD 1.4) 31828 2 (SD 0) 906098 
  Solvent 16.3 (SD 5.6) 34091 2.8 (SD 3.5) 911539 
  ENU 76.7 (SD 20.7) 57253 74.7 (SD 17.7) 916467 
Week 5 Unexposed 74 (SD 21.2) 45860 36 (SD 48.0) 930156 
  Solvent 122 (SD 20.6) 37889 1.5 (SD 1.7) 910060 
  ENU 133.8 (SD 10.8) 42701 98.5 (SD 45.9) 926419 
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3.4.1 Analysis of mutated reticulocytes (RETs) after ENU exposure of mice  
The number of mutated RETs was analysed by the Pig-a assay in samples pre-exposure 
(before exposure to ENU), two weeks and five weeks after exposure in order to examine the 
performance of the assay. Figure 3.12 shows the number of mutated RETs in mice after 
different treatments (unexposed, vehicle and ENU) over a time course of five weeks.  
 
Figure 3.12 Mutation load in reticulocytes (RETs) of mice from pre-exposure to five weeks after 
administration analysed by the Pig-a assay. The time course curve shows the number of mutated RETs pr. 10
5
 
counted cells in unexposed mice (n=2), solvent treated mice (n=4) and ENU exposed mice (n=6) from analysis. 
Data from table 3.6 are used to make the plot. 
The amount of mutated RETs was considerably higher than expected for all treatment groups 
pre-exposure. The figure shows a clear time-dependent increase of mutated RETs in the 
ENU exposed animals. The amount of mutated RETs in the unexposed and solvent treated 
mice had a similar trend with a decrease in mutated cells from pre-exposure to week two and 
an increase in mutated cells from week two to week five. The high number of mutated RETs 
pre-exposure and generally variable amount of mutations in the control and vehicle treated 
mice shows that the analysis of mutated RETs needs to be optimised. No further statistical 
analyses was therefore conducted. 
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3.4.2 Analysis of mutated mature red blood cells (RBCs) after ENU exposure 
of mice  
The number of mutated RBCs was analysed by the Pig-a assay in samples from pre-
exposure, week two and week five in order to examine the performance of the assay. Figure 
3.13 shows the number of mutated RBCs in mice after different treatments over a time 
course of 5 weeks.  
 
Figure 3.13 Mutation load in mature red blood cells (RBCs) of mice from analyses pre-exposure to five weeks 
after administration analysed by the Pig-a assay. The time course curve shows the number of mutated RBCs pr. 
10
5
 counted cells in unexposed mice (n=2), solvent treated mice (n=4) and ENU exposed mice (n=6). Data 
from table 3.6 are used to make the plot. 
Figure 3.13 shows a clear time-dependent increase of mutated RBCs in the ENU exposed 
animals. The solvent treated animals had a generally low mutation load, while the unexposed 
animals showed an increase in the amount of mutated RBCs after five weeks. However, the 
unexposed group only consisted of two animals. The observed increase in mutated mature 
RBCs was comparable to results obtained in other labs. Statistical analyses were performed 
on the data to verify that the observed induction of mutations by ENU was statistically 
significant.  
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Data for the mutated mature RBCs was normally distributed (p>0.649) and meet the 
requirements for a one-way ANOVA. There were statistical significant differences 
(p<0.001) in amount of mutations following the time course curve. A Fisher LSD (least 
significant difference method) post hoc test was then conducted and showed a statistical 
significant increase in mutated RBCs from ENU exposed animals at pre-exposure compared 
to week 2 (p<0.001) and week 5 (p<0.001) after exposure. There were no statistical 
significant increase in the amount of mutations from week two to week five (p=0.168).  
Data from vehicle and ENU exposed mice were compared, in order to examine if there were 
statistical significant differences in mutations between these two treatments. The unexposed 
animals were not included due to the low number of animals (n=2). Data from samples pre-
exposure and week two in vehicle treated animals were not normally distributed (p<0.005), 
and the non-parametric Mann-Withney test was therefore conducted to compare data in the 
two groups. There were statistical significant differences between vehicle and ENU exposure 
at week 2 (p=0.01) and at week 5 (p=0.01) in the amount of mutated RBCs. There were no 
statistical significant difference between vehicle and ENU exposed animals in the amount of 
mutations at pre-exposure (p=0.267).  
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4. Discussion 
As indicated in the introduction, the genomic integrity of human cells is constantly 
influenced by environmental mutagens. The effects of these compounds on both somatic and 
germ cells have gained increased attention during the last decades. It is suggested that these 
compounds contribute to the decreased fertility observed in couples in the industrialised 
world. In this project, the aim was to study the effects of the environmental toxicant BaP, on 
the DNA in male germ cells. As described in chapter 1.7, BaP is distributed to several tissues 
where metabolism converts BaP into metabolites that may have toxic effects on human cells. 
Many of these metabolites have ability to react with the DNA, including radical cations and 
PAH-0-quionones. The most deleterious metabolite is considered to be the ultimate 
carcinogen BaP-7,8-diol-9,10-epoxide (BPDE) (Conney 1982; Sims et al., 1974). The low 
repair capacity in sperm cells at later stages of the spermatogenesis contributes to a possible 
transmission of BPDE-DNA adducts to embryonal DNA following fertilisation (Zenzes et 
al., 1999b). Furthermore, a study on human surplus embryos from IVF treatment have 
suggested that paternally transmitted BPDE-DNA adducts also can persist past the first 
embryonic cleavage divisions (Zenzes et al., 1999b).  
4.1 Testicular toxicity of BaP  
In this study, BaP was administered by i.p. to animals as a single dose of 150 mg/kg/bw. 
This dose was below an acute LDlo dose at 500 mg/kg/bw found for mice after i.p injection 
(Epstein et al., 1972). In dominant lethality studies of mice it has been shown that paternal 
BaP exposure to i.p. doses of 100 and 500 mg/kg/bw in the 1-2 weeks preceding fertilisation 
induced increased rate of embryo losses (Generoso et al., 1982; Shukla and Taneja 2001). 
The sperm cells used in our IVF experiments was exposed to BaP in vivo for 4 days prior to 
IVF. The fertilisation rate in these experiments was only slightly reduced by BaP exposure 
(Ryan 2011, unpublished). This indicates that BaP-exposed sperm cells are able to fertilise 
the oocyte, although BaP is highly embryo-toxic.  
Mice in the SCSA experiment were sacrificed ten days after exposure. The passage of 
spermatozoa through the epididymis takes approximately ten days in both mice and humans 
(Moore 1998; Oakberg and Diminno 1960; Rowley et al., 1970). Thus, sperm cells were 
located between the rete testis and caput epididymis when exposed to BaP. These cells are 
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elongated and have a reduced repair capacity because of the condensed nature of chromatin. 
Accordingly, BPDE-DNA adducts levels were shown to be high both four and sixteen days 
after BaP-exposure in mice (Olsen et al., 2010). Sperm cells collected from the cauda 
epididymis ten days after BaP-exposure in the SCSA experiments were therefore assumed to 
have a high level of DNA damage. The lack of DNA repair in sperm, suggests that human 
males that are exposed to a relatively high doses of BaP via for instance continuously high 
intake of cigarette smoke or extensive occupational exposure may accumulate BPDE-DNA 
adducts in their sperm DNA. This may affect their fertility potential, and is supported by the 
observed association between smoking and reduced fertility (Irvine et al., 2000; Künzle et 
al., 2003; Vine 1996).  
The doses and exposure route used in the lethality studies and in the experiments of the 
present master are high compared to what a human population normally are exposed to. A 
realistic exposure scenario is low doses over a long period of time (chronic exposure). Sub-
acute and chronic studies of BaP-exposure reveal effects on testosterone levels in addition to 
BaP-induced DNA damage (Inyang et al., 2009). The benefit of using a single high dose of 
BaP is the opportunity to specifically measure effects of exposure of early to middle 
spermatozoa, a maturation stage that is associated with the induction of dominant lethality 
(Generoso et al., 1982; Shukla and Taneja 2001). In addition, statistical significant results 
can be obtained with a reduced number of animals compared to a low-dose exposure 
scenario. The effect of genotoxic chemicals is assumed to be linear with the dose. A high 
dose of BaP can therefore be used to extrapolate low dose effects.  
4.2 DNA integrity of BaP exposed sperm as measured by the SCSA 
The SCSA was used in the present master in order to examine if the assay could detect BaP-
induced DNA damage in sperm cells from mice. This was based on the knowledge that BaP 
is a DNA disturbing toxicant that induces embryo lethality following paternal exposure 
(Generoso et al., 1982; Sims et al., 1974; Verhofstad et al., 2010; Xue and Warshawsky 
2005). Advantages with the SCSA are that the assay is well-proven, extensively used and is 
based on flow cytometry, which is a valuable tool for measuring thousands of cells in short 
time. The SCSA is also inexpensive and relatively easy to perform. The assay measure pre-
existing or denaturation-induced single or double stranded breaks in the DNA, but are unable 
to detect the cause of the strand breaks.  
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4.2.1 The SCSA indicated no difference in DNA damage between treatment 
groups   
In the present BaP-experiment, no statistical significant differences in the degree of DNA 
damage expressed as mean Alpha t and % DFI was observed between sperm cells from mice 
after different treatments (control, vehicle and BaP). Previous SCSA experiments have 
shown that smoking men and men exposed to air pollution had elevated level of DNA 
damage expressed as % DFI in sperm cells compared to controls (Potts et al., 1999; Rubes et 
al., 2010). However, it is not confident that BaP in particular causes DNA damage in form of 
strand breaks. Our study indicates that BaP does not cause this kind of damage. There are 
numerous other compounds in air pollution and cigarettes smoke than BaP, and this together 
with long-term exposure of humans may give a completely different result in the SCSA than 
measurements of BaP alone.  
There were a few animals that showed increased % DFI values (table 3.2). This was 
observed in one of the animals in the oil treated Ogg1
wt
 group (32.59%) and another in the 
BaP exposed Ogg1
wt
 group, with the high value of 70.57 % DFI. The latter animal also gave 
high values in the mean Alpha t parameter compared to the other animals in the experiment. 
Because of the enhanced responses in these two animals, the mean values and standard 
deviations (SD) were increased for the % DFI parameter in these groups. Even if the genetic 
background in these mice is similar, it is expected that animals experience different stress 
level caused by external factors, and hence may respond differently to exposure. The results 
indicate that these animals were more susceptible to exposure than the other animals, which 
is generally accepted in human populations as well. The SCSA is a method with high 
sensitivity, and human mistakes may also occur. Inaccuracy in the acid denaturation step or a 
delay during the flow analyses could be plausible reasons for some elevated values in the 
result. However, this type of bias would have been discovered during the analysis. Previous 
pilot experiments with the SCSA performed at the MIKT-lab have shown that a denaturation 
time of 60 seconds instead of 30 seconds gave only a slight increase in % DFI, and not as 
high as up to 70 % which is shown in the BaP treated Ogg1
wt
 animal in this study. Since this 
was a biological experiment it is not accurate to eliminate these data from the result even if 
they may look like outliers, and the statistical analyses were therefore performed with these 
data. A higher number of animals in the experimental groups would have been useful to 
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confirm if the observed enhanced values were characteristic for these kinds of experiments 
or random.  
% DFI is believed to be the most sensitive SCSA parameter (Evenson and Jost 2000), and 
this was confirmed in the preliminary SCSA experiment with a dose-response analysis of 
sperm cells after DNase exposure. The % DFI parameter reached a saturated level after a 
dose of 0.2 U/ml DNase, while the mean Alpha t value in the same experiment increased in a 
fairly linear way following higher doses (figure 3.1). This indicates that % DFI potentially is 
a good parameter for studying genotoxic compounds, although the parameter may be 
unsuited in some toxicological animal experiments. A highly sensitive parameter could 
easily reach saturation, and this has been observed in an earlier master thesis at the MIKT-
lab, where the % DFI parameter easily reached saturation in sperm cells exposed to 
acrylamid (Shahzadi 2008, unpublished). Since BaP did not generate increased DNA 
damage measured as strand breaks in the present project, and % DFI is a sensitive parameter, 
this further indicate that this kind of damage is not present in the sperm cells after BaP-
exposure.  
4.2.2 Effects of BaP on sperm DNA damage in Ogg1-/- mice 
In studies of exposure to specific compounds in experimental animals, the use of transgenic 
mice is often valuable. Knock out of desirable genes can be used to increase the knowledge 
of cellular mechanisms, and increase the relevance of animal studies to humans. The Ogg1
-/-
 
mice used in the present BaP-experiment were deficient in repair of the oxidative DNA 
lesion 8-oxoG, due to a knock out of the OGG1 gene for DNA glycosylase (Klungland et al., 
1999). Human testicular cells have a lower degree of repair capacity of oxidative DNA-
lesions such as 8-oxoG than mice (Olsen et al., 2003). Hence, these Ogg1
-/-
 mice are often 
used as a model for human testicular toxicity studies. A lower repair capacity may result in a 
higher background level of oxidative DNA lesions in sperm from Ogg1
-/-
 mice compared to 
Ogg1
+/+
, possibly rendering them more sensitive to additional damage. The extent of DNA 
damage was therefore assumed to be similar or higher in the Ogg1
-/-
 animals compared to 
Ogg1
+/+
 (or Ogg1
wt
). However, BaP exposed Ogg1
-/-
 mice rather had a slightly lower mean 
value compared to BaP exposed Ogg1
wt
 mice for the % DFI parameter (figure 3.5). There 
were no statistical significant differences between the two groups in the % DFI parameter. 
This indicates that a deficiency in repair of 8-oxoG did not generate any higher level of DNA 
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damage compared to mice with a higher repair capacity (Ogg1
wt
), at least as was 
measureable by the SCSA.   
The data from the % High green parameter demonstrated no statistical significant differences 
between treatment groups in the wild type animals. However, animals in the BaP-exposed 
Ogg1
-/-
 group showed statistical significant lower mean values compared to the groups with 
wild type mice (figure 3.6). Sperm cells in the High green parameter are cells with a higher 
stainability of dsDNA by acridine orange (AO). These cells are believed to be immature 
sperm cells without fully protamine condensed chromatin, which allows a higher 
accessibility of the nucleic dye (Evenson and Jost 2000). The reasons for statistical 
significant lower levels for these sperm cells in the BaP exposed Ogg1
-/-
 mice are unclear.  
The oxidation of protamine thiols plays an important role in sperm maturation (Pfeifer et al., 
2001). A potential explanation may thus be that the combination of BaP-exposure and a 
decreased repair capacity induce a moderate oxidative stress that promotes the condensation 
of sperm chromatin. This could lower the amount of immature cells in the cauda epididymis. 
Alternately, the decreased repair capacity may also result in a higher level of apoptosis in 
sperm cells from the BaP exposed Ogg1
-/-
 mice. If this apoptosis was selective towards 
immature cells due to their weaker chromatin configuration, a lower total amount of 
immature cells could be present in a sperm sample. Furthermore, the % High green 
parameter is not as precise as the other SCSA parameters because measurements of cell 
doublets have been observed (Evenson and Jost 2000). Cell doublets are a concept in flow 
cytometric analysis where two cells are physically attached to each other or pass through the 
laser beam so close that they are detected as a single event by the cytometer. The cell 
doublets normally comprise a very small percentage of the total population, and should 
probably be present in the other groups of mice as well. It would be interesting to observe if 
the % High green parameter was reduced in the control and vehicle Ogg1
-/-
 mice as well, or 
if BaP-exposure was the reason for a reduced value in the BaP exposed Ogg1
-/-
 mice. 
However, this was not possible to examine in this project due to the erroneous genotyping 
mentioned in chapter 3.1.2, and this short coming makes it difficult to achieve the aim of 
comparing the two genotypes.  
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4.2.3 Limitations in the SCSA for measuring BaP-induced DNA damage 
Sperm DNA damage is difficult to measure due to the highly compact nature of sperm DNA. 
Although the SCSA is widely used and measure single and double stranded DNA breaks 
with great efficiency, the results from this study indicate that BaP-exposure of early and 
middle spermatozoa do not make the chromatin in sperm cells more unstable, and the 
damage is thus not measurable by the SCSA. Studies have shown that BaP give a high 
amount of BPDE-DNA adducts in sperm (Olsen et al., 2010; Sipinen et al., 2010), meaning 
that these adducts were present in the chromatin of BaP exposed mice. The induction of 
embryo lethality stresses the need for an alternative assay that can reveal BaP-induced sperm 
damage. However, the SCSA results suggest that embryo toxicity induced by paternal BaP 
exposure is related to DNA adduct formation and not to secondary formation of DNA strand 
breaks in paternal DNA. This is in contrast to acrylamid that also has shown to induce 
dominant lethality, but where both DNA-adducts and DNA breaks is considered to play a 
part (Marchetti and Wyrobek 2005; Brevik, manuscript in preperation).  
4.3 Establishment of an immunostaining procedure for BPDE-DNA 
adducts 
One of the aims for this master project was to set up an immunological method suited for 
staining of BPDE-DNA adducts. The ultimate goal was to use this method to examine if 
sperm BPDE-DNA adducts persist in pre-implantation embryos after paternal exposure to 
BaP. Immunostaining techniques has previously detected BPDE-DNA adducts in other 
tissues, including both oocytes and sperm cells (Zenzes et al., 1998; Zenzes et al., 1999a; 
Zhang et al., 1998). Successful staining of BPDE-DNA adducts in embryos after paternal 
BaP-exposure has also been performed with surplus embryo from IVF treatments (Zenzes et 
al., 1999b). Zenzes study of paternal transfer of BPDE-DNA adducts was performed on a 
small sample size and indirect exposure of the mother could have occurred. A part of the aim 
for this master was to establish a more robust method that could be applied to larger number 
of embryos and under controlled exposure conditions.  
Immunostaining of BPDE exposed hepatoma cells in vitro confirmed that the procedure 
worked, with clear staining of BPDE-DNA adducts (figure 3.8). The use of clots for 
capturing embryos before staining was believed to give a more efficient staining procedure 
without need for mouth pipetting in every stage. Since embryos on slides were easily lost, 
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capture in clots was also believed to reduce this problem. Experiments with oocytes in 
fibrinogen clots on slides are performed earlier with other immunostaining procedures (Hunt 
et al., 1995; Shahzadi 2008, unpublished). Because of the denaturation step in the procedure 
for staining BPDE-DNA adducts, fibrinogen clots were dissolved and we concluded that 
these clots was unsuited. Subsequently, agarose clots were tried and these were able to 
capture embryos and did tolerate the denaturation step. However, the results were poor for 
staining of embryos after BaP-exposure both in vivo and in vitro together with in vitro 
exposed oocytes. Testicular somatic cells were also exposed to BPDE as a positive control to 
test the procedure, and there were no staining of BPDE-DNA adducts in testicular cells as 
well. Since the same procedure gave efficient staining of adducts in hepatoma cells at an 
earlier stage, there are really no logical explanation for why the procedure suddenly did not 
work. We concluded that there was a methodological failure. This failure where not 
resolved, due to the time limit of this master thesis. The main focus for the immunostaining 
part of this master became testing of the method. Although the results were poor, a method 
for capturing embryos in agarose is now established at the MIKT-lab and the procedure for 
immunostaining for BPDE-adducts has been optimised.   
A successful staining of BPDE-DNA adducts in embryos would have indicated whether 
exposure to BaP in vivo to male mice could give DNA adducts that are transferred to 
embryonal DNA following fertilisation. It could also give information of whether known 
BPDE-DNA adducts were present in later stages of the embryo. For a further link to humans, 
this could have indicated that a smoking father have potential to transfer BaP-induced 
adducts and disturb a healthy embryonal development of his offspring, as suggested by 
studies by Zenzes (Zenzes et al., 1999b). 
4.4 Promising results for the somatic mutation assay Pig-a 
Establishment of the Pig-a assay at the MIKT-lab was one of the aims for this project. This 
work has been performed with support from the Litron laboratories, and continuous 
improvements increase the sensitivity of the assay. The pilot experiments in the present 
master project has provided knowledge about the assay qualities, and been a part of 
establishing a protocol for the Pig-a assay at the MIKT-lab. Several laboratories are using 
the prototype kit provided by Litron with mutual solutions for comparison of results, and the 
Pig-a assay has proved to be promising. The Pig-a assay has shown to be relatively quick to 
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perform, it takes approximately one day from collecting blood samples to completed flow 
analysis, in a sample size with blood from ten animals. Since the acquired volume of 
withdrawn blood from each animal is relatively small, animals are not very affected and the 
assay can be used in combination with long-term exposures in evaluation of chemicals. In 
vivo mutation assay are needed, and the Pig-a assay could be included into 28-days repeated 
dose standard toxicological studies of chemicals. However, the Pig-a assay only measure 
mutations in a single gene whose sensitivity to various types of DNA damage has not yet 
been well defined. Since the Pig-a gene is located on the X chromosome it is expected to 
identify only a part of the mutations that can be detected with an autosomal reporter gene 
(Dobrovolsky et al., 2010). The assay is also relatively new, and limited data have been 
generated on the fact that all GPI marker deficient cells have mutations in the Pig-a gene. 
Pig-a mutations in other tissues than blood are also presently not well established. This study 
has shown that the assay was sensitive and well repeatable. It was also shown that the assay 
had some background level of false positive mutated reticulocytes (RETs).  
4.4.1 Pilot experiments  
The dose-response analysis with a mixture of an increasing amount of unlabelled “mutant 
mimic” cells (CD24 negative) and labelled cells (CD24 positive) indicated that the assay was 
able to detect cells with a mutant phenotype. This was best detected in mutated mature red 
blood cells (RBCs), with a correct detection of a ten fold increase in mutated cells in the 
dilution series (table 3.3). The amounts of mutated RETs were variable and showed a 
background of false positive cells in the control sample (table 3.3). In mutation assays that 
use samples with red blood cells, the key parameter to examine is the amount of mutated 
RETs. RETs are young and recently produced in the bone marrow (chapter 1.15), while the 
erythrocytes are older and already circulating in the blood pool. Erythrocytes may thus been 
through a selection of healthy cells and apoptosis of mutated ones, which could provide an 
incorrect picture of the actual mutated number of cells in a sample caused by the compound 
tested. In contrast, RETs are assumed to contain all the mutated and non-mutated cells. To be 
able to measure effects in RETs, the chemicals tested needs to reach and affect cells in the 
bone marrow. This limitation is also true for the micronucleus assay.  
Labelling of platelets and lymphocytes gave information about localisation of these cells in 
Pig-a flow cytograms. This experiment was performed due to the observed amount of false 
positive RETs. We wanted to examine if some of the platelets or lymphocytes was still 
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present after the red blood cell preparation during the Pig-a procedure, and possibly was 
detected as false positives. Due to different sizes of the various mammalian blood cells 
together with antibody (labelling of platelets) and Syto13 labelling (nucleic acid dye), we 
were able to establish the localisation of these in the cytogram compared to the red blood 
cells. The small platelets were displayed below the red blood cells, while the larger 
lymphocytes were displayed above (figure 3.10a). This experiment confirmed that only a 
small amount of platelets and lymphocytes were present in a sample with isolated red blood 
cells (figure 3.10 b), and are probably not the reason for the repeated level of false positive 
RETs observed. However, it is important to be aware of this when making conclusions of 
results from the assay. Establishment of where platelets and lymphocytes are localised, 
makes the gating for future Pig-a experiments more stringent and reliable, and contamination 
of samples for Pig-a analyses can more easily be avoided.  
4.5 Performance of the Pig-a in response to ENU-treatment in mice 
The Pig-a experiment with ENU exposure to mice, was conducted as a positive control for 
the assays performance in our lab, compared to other similar experiments. Earlier 
experiments with performance of the Pig-a assay using different mutagens, including ENU, 
has shown an increased frequency of mutated cells (Miura et al., 2008; Phonethepswath et 
al., 2008; Phonethepswath et al., 2010). ENU-exposure of mice in our project gave a 
statistical significant increase in number of mutated RBCs detected by the Pig-a assay, 
following a time period of five weeks. However, the results for mutated RETs were variable 
and indicated the detection of false positive cells. The assay detected a relatively high 
amount of mutated RETs pre-exposure (before treatments) in all animals (figure 3.12). The 
mutation load in animals at this time is expected to be low. The analysis two weeks after 
exposure showed that amount of mutations in control animals was decreased. In the Pig-a 
analysis pre-exposure, the technique with preparation of all blood samples may not have 
been incorporated well enough, and the gating performed in the calibration standard may 
have been performed more liberal in this analysis. This could give a higher amount of RETs 
measured as mutants pre-exposure, and explain the decrease in amount of mutations 
analysed in week two. Since this experiment was a part of establishing the Pig-a assay, 
further statistical analyses on the clearly unstable measurements of RETs was not conducted. 
The aim was to increase the knowledge of the assay for further studies. Results from other 
laboratories (Miura et al., 2009) have shown that the mutations in RETs occur earlier in time 
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(one week) than mutations in RBCs. Furthermore, the mutation frequency was shown to be 
higher in RETs than in RBCs, suggesting a removal of mutated mature RBCs.  
The measurements of mature red blood cells (RBCs) showed statistical significant 
differences from pre-exposure to both week two and week five, and no such difference from 
week two to week five (figure 3.13). This indicates that ENU generate a higher increase in 
mutations in the first two weeks, followed by a decrease in the rate of new mutations for the 
next three weeks. The mutation load pre-exposure in RBCs was very low (figure 3.13), 
which shows a low background of false positive RBCs compared to false positive RETs. 
Since the results from mutated RBCs showed a more satisfactory result, further statistical 
analysis was conducted. The result showed that ENU treated animals had a statistical 
significant higher amount of mutations than vehicle treated animals in both week two and 
week five. There were no statistical significant differences of mutation load between ENU 
and vehicle animals pre-exposure. The experiment indicated that the assay can measure 
mutations in RBCs with high sensitivity. The results of the analysis of mature RBCs was in 
agreement with other labs (Miura et al., 2009).  
4.5.1 Improvement for the Pig-a assay and future relevance 
It is currently ongoing work with improving the performance of the Pig-a assay, including 
experiments for reducing the amount of false positive RETs. The number of mutated cells in 
a blood sample is generally low, and by increasing the amount of cells that are counted by 
the flow cytometer for each sample, more reliable results could be achieved. Since the assay 
is using flow cytometry, gating can be made in the cytogram that only take RETs into 
account, since these are the most valuable cells to study in a mutation assay with red blood 
cells. Recently a new antibody with higher affinity towards the surface marker for the GPI-
anchor has shown to reduce the amount of false positive RETs detected by the assay.  
A future goal for the MIKT-lab regarding the Pig-a assay is a completely established assay 
that can be applied as a supplementary test to other studies. This assay will be examined for 
the possibility of using the mutation frequency in somatic cells as a proxy for the mutation 
frequency in germ cells. The ultimate goal would be analyses of human samples. This is also 
needed in order to examine if the assay is functional in humans. If this proves to be the case, 
the assay could be applied in the work with establishment of genotoxicity data in human 
biomonitoring.  
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4.6 Conclusions 
BaP-exposure of male mice in vivo did not generate enhanced levels of DNA damage in 
sperm cells analysed by the SCSA. This indicates that the SCSA is an unsuited method for 
examination of BPDE-DNA adducts although it is a well used and established method in 
humans. Furthermore, the results indicated that BaP exposure does not induce secondary 
DNA strand breaks in sperm cells. A decreased value of sperm cells in the % High green 
parameter was observed in BaP-exposed Ogg1
-/-
 mice compared to wild type animals. 
Whether this decrease was due to the genotype in general or the combination of BaP-
exposure and genotype was not possible to determine in this study, because control and 
vehicle treated mice were absent for the Ogg
-/- 
genotype.  
Establishment of a method for immunostaining of BPDE-DNA adducts in embryo, was 
technically challenging. Hepatoma cells exposed to a high dose of BPDE in vitro gave 
detectable adducts and confirmed that the procedure worked. We managed to establish a 
method for capturing embryos inside clots of agarose, however, the staining for BPDE-DNA 
adducts in these embryos after exposure both in vitro and in vivo were poor. The study of 
paternal transfer of BPDE-DNA adducts to embryo DNA is incomplete and we were not able 
to proceed to further staining of adducts in second and four cell stages of the embryo. The 
reason for this is believed to be methodological, and the problem was not solved do to the 
time limits of this master. Despite poor results in this part of the project, we have gained 
knowledge of the procedure and have excluded several approaches in the development of the 
method. This will be a significant advantage in further studies with staining of BPDE-DNA 
adducts in embryos.  
The establishment of the Pig-a assay has showed that the assay is promising and has great 
sensitivity for detection of mutant mature red blood cells (RBCs). This was proved in a 
positive control with ENU-exposed mice, and a dose-response experiment with “mutant 
mimics”. These experiments have also indicated that the assay needs improvement regarding 
the sensitivity for detection of mutated reticulocytes (RETs). The assay seems promising for 
measuring somatic mutations, and it is now an established protocol for the assay at the 
MIKT-lab that is under current improvements. This includes separate analysis of mutated 
RETs and the use of an antibody with higher affinity towards the GPI-anchor marker. The 
amount of cells examined for each sample is also increased. The Pig-a assay has potential for 
regulatory toxicology and in the study of environmental mutagens. 
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4.7 Future work 
Measurements of sperm DNA-integrity is complicated due to the highly compact DNA in 
sperm. Since the SCSA showed poor results for detection of BaP-induced DNA damage, 
other assays are needed for this purpose. Measurements of DNA damage in mitochondrial 
DNA in sperm cells, instead of nuclear DNA is one method that are under consideration at 
the MIKT lab (Ryan 2011, unpublished). Preparation for further studies on immunostaining 
of embryos is under current consideration at the MIKT-lab to answer the questions of DNA 
adduct persistence in pre-implantation embryos. The Pig-a assay is presently under 
development and improvement. A future study on mutagenic effect of BaP in somatic cells 
would be of great interest and a study is planned to compare the mutation frequencies in 
somatic and germ line cells following BaP exposure.  
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6. Appendix 
6.1 Solutions and media 
6.1.1 SCSA 
DNase buffer  
100ml ddH2O 
40mM Tris-HCl 
10mM NaCl  
6mM MgCl2  
10 mM CaCl2 
pH adjusted to 7.9 with 1M NaOH 
0.1 % Triton Dnase buffer 
100 µl Triton X-100 
10 ml Dnase buffer 
DNase  
1mg/ml ddH2O (200 U/ml) 
TNE buffer, 10X 
0.01 M Tris-HCl 
0.15 M NaCl 
1mM EDTA (disodium) 
600 ml ddH2O 
Adjusted pH to 7.4 with 10 mM NaOH, stored at 4°C 
TNE buffer, 1X  
60ml TNE buffer (10X) 
540ml ddH2O 
pH 7,4, stored at 4°C 
Acid detergent solution  
0.15 M NaCl 
0.1 % Triton X-100 
0.08 N HCl 
500 ml ddH20 
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Adjusted pH to 1.2 with 2N HCl, stored at 4° C 
Citric acid buffer (0.1 M) 
21.01 g citric acid monohydrate, 1 L ddH20 
Stored at 4 °C 
Disodium hydrogen phosphate (Na2HPO4) buffer (0.2 M) 
14.2 g Na2HPO4 
500 ml ddH20 
Stored at 4 °C 
Acridin orange (AO) stock solution (1.0 mg/ml) 
5.5 mg Acridin orange  
5.5 ml ddH20 
Protected from light and stored at 4°C  
Staining buffer  
185ml  0.1 M citric acid buffer 
315ml 0.2 M Na2HPO4 buffer 
186mg EDTA (disodium) 
4.39g  NaCl 
Solved EDTA completely on magnetic stirrer  
Adjusted pH to 6.0 with NaOH pellet 
Stored at 4 °C 
Acridin orange (AO) staining solution 
100ml staining buffer in light-protected bottle 
600 µl AO stock solution 
Stored at 4 °C 
AO equilibration buffer 
400 µl acid detergent solution, 1.2 ml AO staining solution 
6.1.2 Immunostaining  
Tris Buffer (10mM Trizma base, 1 mM EDTA, 0.4 M NaCl) 
10 mM Trizma base 
1mM EDTA 
0.4 M NaCl 
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1 L ddH2O 
Adjusted pH to 7.5 with NaOH, stored at 4 °C 
Tris base solution  
50 mM Trizma base, 1L dd-H2O 
Stored at 4 °C 
Blocking solution 
5 % BSA with 0.01 % Thimorosal  
Stored at 4 °C 
PBD (0.1 %) 
1L PBS, 1mL Triton X100 
Stored at 4 °C 
Proteinase K  
10 µg Proteinase K, 1 mL Tris buffer 
Stored at 4 °C 
6.1.3 Pig-a 
Solutions used in the preliminary Pig-a experiments 
Leukodepletion gradient (Nycoprep, Lymphoprep, Lympholyte) 
Heparin in PBS (1:10) 
Syto13 (0.157 µM in PBS) 
AntiCD24-PE conjugated (1:20 in 2% FCS in PBS) 
AntiCD42-APC conjugated (1:10 in 2% FCS in PBS) 
Solutions used from Litrons prototype kit 
Lympholyte 
Anticoagulant solution 
Buffered Salt Solution (BSS) 
Working Antibody Solution (antiCD24-PE)  
Working Nucleic Acid Dye Solution (Syto13) 
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6.2 Products and producers  
Product Producer 
Acridin Orange VWR International, USA 
Acetone VWR International, USA 
Agarose Sigma-Aldrich, Norway AS 
Anti Coagulant Solution Litron laboratories, USA 
BD
TM
 cytometer setup and Tracking beads (Lot id 66656) BD Bioscience, USA 
Benzo(a)Pyrene Sigma-Aldrich, Norway AS 
Bovine serum albumin (BSA) Sigma-Aldrich, Norway AS 
BPDE National Chemical laboratories, USA 
Buffered Salt Solution (BSS). Litron laboratories, USA 
Calium chloride (CaCl) Merck chemicals, USA 
Citric acid monohydrate Merck chemicals, USA 
Corn Oil Sigma-Aldrich, Norway AS 
Dako cytomation fluorescence medium Dako Norway 
Dimethyl sulphoxide (DMSO) Sigma-Aldrich, Norway AS 
Disodium hydrogen phosphate (Na2HPO4) Chemi-teknik AS, Norway 
Distilled water (ddH2O) NIPH, Norway 
DNase Roche Diagnostics, Norway AS  
EDTA VWR International, USA 
Fibrinogen Merck chemicals (Calbiochem), USA  
Fetal calf serum (FCS) Med Probe, Norway 
Flow cytometer, BD LSR II BD Bioscience, USA 
HCG (Human Chorionic Gonadotropin) Merck chemicals (Sereno), USA  
Heparin Pharma AS, Denmark 
Hoechst 33342  Invitrogen, USA 
HTF medium EmbryoMax, Millipore, USA 
Hyase Vitrolife, Sweden 
Hydrogen chloride (HCl) Merck chemicals, USA 
KSOM EmbryoMax Millipore, USA 
Lympholyte Cedarlane labs, Canada 
Lymphoprep Medinor, Norway 
M2 medium  Sigma-Aldrich, Norway AS 
Magnesium chloride (MgCl) Sigma-Aldrich, Norway AS 
Methanol Sigma-Aldrich, Norway AS 
N-ethyl-N-nitrosourea (ENU) Sigma-Aldrich, Norway AS 
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Nycoprep Fresenius Kabi, Norway AS 
Paraffin (liquid) MediCult, Norway 
Phosphate buffer solution (PBS)  Chemi-teknik AS, Norway 
PMSG (Pregnant Mare Serum Gonadotropin) Intervet (Folligon), Norway 
Primary antibody mAb anti-5D11  Nordic BioSite AS, Norway 
Primary antibody antiCD24-PE eBioscience, Canada 
CD42d-APC eBioscience, Canada  
Proteinase K Sigma-Aldrich, Norway AS 
Queens Advantage Protein PlusTM Fertilization (HTF) Medium EmbryoMax, Millipore, USA 
Rnase-it Qiagen GmbH, Germany 
RPMI medium 1640 Sigma-Aldrich, Norway AS 
Secondary antibody donkey anti-mouse (Alexa:488)  Invitrogen, USA 
Sodium chloride (NaCl) Sigma Aldrich Norway AS 
Sodium hydroxide (NaOH) Merck chemicals, USA 
Syto13  Invitrogen, USA 
Thimorosal Sigma Aldrich Norway AS 
Triton-X100 VWR International, USA 
Trizma base Sigma-Aldrich, Norway AS 
Trizma Hydrochloride, Tris-HCl Sigma-Aldrich, Norway AS 
Thrombin Sigma-Aldrich, Norway AS 
Tryphan blue  VWR International, USA 
Trypsin  VWR International, USA 
Working antibody solution Litrons laboratories, USA 
Working Nucleic dye Solution Litrons laboratories, USA 
 
